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1. Abstract 
Healthy multiparous Holstein-Fresian cows (n=101, parity ≥ 2) from 3 large-scale dairy herds in 
Italy were subjected to an intravenous glucose tolerance test (GTT) 14-1 d before (Week -1) and 
3-9 d after calving (Week +1). A single blood collection was repeated 10-16 d after calving. 
Several plasma metabolites and insulin were determined at basal samples (T0); Revised 
Quantitative Insulin Sensitivity Check Index (RQUICKI) and Homeostasis Model Assessment 
(HOMA) for the estimation of peripheral insulin sensitivity were also calculated at T0. Insulin 
and glucose were also measured 10 (T10) and 80 (T80) minutes after glucose infusion. T80/T0 
glucose ratio in Week -1 was used for cows’ classification in two categories: GTT class 1 = cows 
with T80/T0 > 1.2; GTT class 0 = cows with T80/T0 ≤ 1.2. First milk test productions, diseases 
and mastitis cases were recorded. Cows in GTT class 0 and 1 in Week -1 differed both for 
glucose concentration at T0 and glucose at T80 (P < 0.01). Cows in GTT class 1 had a relative risk 
of 2.18 of having NEFA higher than 0.5 mEq/l pre-partum (P < 0.05). There was a significant 
herd effect over NEFA, Glucose, Insulin, Albumins, Urea, GOT-AST and GPT-ALT at T0 pre-
partum (P < 0.05); post-partum herd effect was confirmed for Glucose and RQUICKI (P < 0.05).  
In the pre-partum weeks interestingly different levels of plasma insulin at T10 were evidenced 
within GTT class with lower hormone concentrations in class 1 (P < 0.01). Those cows also 
reported post-partum higher HOMA values (P < 0.01) and lower RQUICKI (P < 0.05), which 
reflect decreased insulin sensitivity. In conclusion, our study demonstrates a promising 
opportunity for application of surrogate indices of insulin sensitivity and GTT in field trials to 
detect insulin resistance syndrome in dairy cows in the future. The T80/T0 ratio derived by GTT 
seemed to be useful in detecting a low insulin secretion as a likely complication of altered 
glucose uptake following glucose load in transition cows. 
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2. Riassunto 
101 bovine di razza Holstein-Fresian, pluripare (> 2 parti) e in buono stato di salute, selezionate 
all’interno di 3 grandi aziende di bovine da latte in Italia, sono state sottoposte al test da carico 
intravenoso del glucosio a 14-1 giorni prima (Settimana -1) e a 3-9 giorni (Settimana +1) dopo il 
parto. Un singolo campione di sangue è stato ripetuto a 10-16 giorni dopo il parto. Diversi 
metaboliti e la concentrazione di insulina sono stati determinati in corrispondenza dei 
campionamenti basali (T0); inoltre a T0 sono stati calcolati l’indice RQUICKI, Revised 
Quantitative Insulin Sensitivity Check Index, e HOMA, Homeostasis Model Assessment per la 
valutazione della sensibilità insulinica periferica. L’insulina e il glucosio sono stati anche misurati 
a 10 (T10) e 80 (T80) minuti dopo l’infusione del glucosio. Il rapporto tra le glicemie rilevate a 
T80 e T0 nella Settimana -1 è stato utilizzato per la classificazione degli animali in due categorie: 
la classe GTT 1 per gli animali con T80/T0 > 1.2; la classe GTT 0 per quelli con T80/T0 ≤ 1.2. Sono 
state inoltre raccolte le produzioni di latte al primo test, i casi di patologie e di mastiti. Le 
bovine in classe 0 e classe 1 per GTT differivano tra loro sia per la glicemia basale che per la 
glicemia a T80 (P < 0.01). La bovine in classe 1 di GTT avevano un rischio relativo pari a 2.18 di 
avere NEFA più elevati di 0.5 mEq/l pre-parto (P < 0.05). E’ stato riscontrato un significativo 
effetto azienda su NEFA, Glucosio, Insulina, Albumine, Urea, GOT-AST e GPT-ALT a T0 pre-parto 
(P < 0.05); post-parto l’effetto azienda è stato confermato per Glucosio ed RQUICKI (P < 0.05). 
Nelle settimane pre-parto sono stati osservati livelli diversi di insulina plasmatica a T10, in 
particolare concentrazioni inferiori dell’ormone sono state messe in evidenza in classe 1 di GTT 
(P < 0.01). Le stesse vacche hanno successivamente riportato valori più elevati di HOMA (P < 
0.01) e valori inferiori di RQUICKI (P < 0.05) post-parto, che riflettono una diminuita sensibilità 
insulinica. Per concludere, il nostro studio dimostra per il futuro una buona possibilità di 
applicazione degli indici surrogati di sensibilità insulinica e del GTT in prove di campo per 
individuare forme di insulino resistenza nella vacca da latte. Il rapporto T80/T0 ricavato dal GTT 
sembra utile nel rilevare una scarsa secrezione di insulina quale probabile complicazione 
dell’assorbimento del glucosio successivo alla sua somministrazione durante il GTT nelle bovine 
in transizione.  
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3. Introduction 
The periparturient period is characterized by metabolic and endocrine changes resulting from 
negative energy balance and  the insulin resistance phenomenon by extra-hepatic tissues (Sano 
et al., 1991; 1993), which helps to primarily direct the flow of nutrients to the fetus and 
mammary gland during last few weeks of gestation and first periods of subsequent lactation 
(Baird, 1981). Insulin resistance syndrome is also assumed as being a decisive factor involved in 
the pathogenesis of metabolic disorders of dairy cows such as ketosis and fatty liver (Hayirli, 
2006). 
 
3.1 Glycaemia: comparison between ruminants and non-ruminants 
Glycaemia usually shows very constant and similar values across different animal species, with 
slight variations within a reference range of 70-100 mg/dl in humans and most domestic 
animals, if measured after few hours of fasting. After a prolonged fasting period the glycaemia 
is steadily preserved as well through a sensitive and complicated regulation mechanism. This 
regulation system is necessary because both hyperglycaemia and hypoglycaemia are noxious to 
the organism. Lasting high levels of glucose, as reported in diabetes, can cause multiple effects 
due to its osmotic pressure in the extracellular fluid, with cellular dehydration and loss of 
glucose in the urine accompanied by osmotic diuresis. In the diabetic patients persistently high 
glucose is also responsible for blood vessel wall damage, and consequently for a higher risk of 
heart failure, ictus, kidney diseases and blindness. Nevertheless animals can bear and put up 
with prolonged state of hyperglicaemia, the hypoglycaemia can be lethal with increasing 
seriousness and severe alterations when glucose gets down 50 mg/dl: headache, dizziness, 
shuddering, convulsions, loss of consciousness and death. All these consequences are caused by 
an insufficient supply of glucose to the brain that cannot loosely utilize alternative energetic 
sources to meet its requirements because of the presence of the haemato-encephalic barrier.  
Unlike all the other species and young ruminants, postprandial plasma glucose concentrations 
range from 40 to 60 mg/dl in adult ruminants, under normal physiological conditions (Hsu and 
Crump, 1989). In ruminants, dietary carbohydrates and proteins are converted to volatile fatty 
acids (VFA) and some other biomolecules (e. g. ammonia and microbial protein) in the reticulo-
rumen, by microbial degradation and fermentation. Only a small amount of glucose passes 
through the reticulo-rumen and is absorbed from the intestine, while the majority of glucose is 
provided via gluconeogenesis in the liver (Young, 1976). Hence, plasma glucose concentration 
in ruminants is lower than that in non-ruminants. Besides ruminants can tolerate larger 
fluctuations of glycaemia than non-ruminants and are less sensitive to the effects of 
hypoglycaemia. For example, glycaemia in sheep reared on pastures ranges between 30 and 60 
mg/dl according to seasons. This may be explained by some important physiological 
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modifications of glucose requirements that occur throughout lactation and pregnancy without 
apparent disorders in ruminants. Typically these changeable situations may include alterations 
of the feed quality along the whole year on pastures, the fetus demand of energetic substrates 
during gestation, and the rapid onset of lactose and milk production after calving. Ruminants 
can face with these priorities because they use VFA (acetic, propionic and butyric acids), 
abundantly produced by ruminal fermentation, as alternative energetic sources. Among these 
VFA, only propionic acid has a strategic rule in gluconeogenesis. Since gluconeogenesis is 
supported by components that favor propionic production, the feed composition can indirectly 
influence the plasma glucose level (Wilson et al., 1983).  
  
3.1.1 Regulation of glycaemia       
The regulation of glucose occurs on multiple levels by cooperation of endocrine and nervous 
systems in order to arouse endocrine, neurological and behavioral responses that all together 
are able to preserve glycaemia from variations (Aguggini et al., 2000). The process of glucose 
homeostasis exhibits oscillatory behavior involving the following principal mechanisms:    
1. Automatic response of the pancreatic islets which secrete glucagon and insulin under 
condition of hypo or hyperglycaemia, respectively. When insulin binds on the cellular insulin 
receptor, it leads to a cascade of cellular processes that promote the uptake of glucose from 
the blood stream, and its usage or, in some cases, its storage in the cell. Insulin is an anabolic 
hormone and acts to preserve nutrients. It has multiple roles in metabolism of carbohydrates, 
lipids and proteins. Glucagon is the most important counter regulatory mechanism to stop the 
activity of insulin beyond a certain limit. 
2. Intervention of the central nervous system (CNS), which stimulates hunger and food research 
and intake, when the glucose reserves are depleting. On the contrary of all the remaining CNS, 
some hypothalamic neurons are sensitive to glucose concentration and require insulin to 
consume glucose. This fact explains the insatiable hunger state in diabetics suffering from 
hyperglycaemia but also deficiency of insulin or inefficiency of insulin action. On the other 
hand, insulin produces satiety only if glycaemia is maintained elevated, otherwise it itself 
causes hypoglycaemia and thus stimulates appetite.  In part insulin secretion is controlled by 
vagus nerve. Either the view of food, food sensing by olfactory and taste receptors or 
conditioned stimuli associated with food determine an insulin release with reinforcement of 
hunger and food interest. 
3. Catecholamine release from adrenal medullary in danger and emergency situation. 
Epinephrine is immediately released in large amount and rapid rush and has acute 
hyperglycaemic effects, including hepatic glycogen lisis and lipolisis in adipocites and muscle. 
4. Adrenal glycocorticoids secretion in several stress situations as trauma, hemorrhagies, 
diseases, poisonings, anaphylaxis, emotional stresses and other general conditions with severe 
 5 
 
homeostatic alterations. In these cases the hypothalamus secretes the CRF (Corticotropin 
Releasing Factor) which in turn stimulates the pituitary gland to release ACTH 
(Adrenocorticotropic Hormone) that promotes glycocorticoids synthesis and excretion in the 
blood. Similarly to epinephrine, their effects are hyperglycaemic because they suppress protein 
synthesis and foster hepatic gluconeogenesis in order to preserve the CNS functionality and be 
able to completely utilize and oxidize fatty acids.  
5. Thyroid gland activity, which basically exerts a hyperglycaemic effect due to an increased 
protein and lipid catabolism, improved intestinal absorption, sympathetic tone and synergic 
action with catecholamine and food consumption.     
6. Somatotropin hormone activity: it has hyperglycaemic effects and is an insulin antagonist 
too, because it depresses glucose uptake and consumption from tissues and preferably 
facilitates the use of adipose reserves to sustain energetic demand of protein synthesis, 
particularly during growth and development, gestation and lactation.    
 
3.1.2 Endocrine Pancreas: 
As an endocrine gland, the pancreas secretes peptide hormones, such as insulin from β cells, 
glucagon from α cells, somatostatin from δ cells, and pancreatic polypeptide from F cells (Hsu 
and Crump, 1989). These cells are located in the clusters known as islets of Langerhans diffused 
among exocrine parenchymal tissue and they constitute 1-3% of the total pancreatic mass with 
approximately 2500 cells in each islet and one million islets in humans. The proportions of β, α, 
δ, and F cells are about 60%, 30%, 8% and 2% respectively (Hsu and Crump, 1989; Hadley, 1996) 
and they strictly control each other hormones secretion within the islet. 
 
3.1.3 Insulin: synthesis and structure 
Insulin biosynthesis is a complex event that is characterized by formation of two insulin 
precursors: preproinsulin, which is composed of acidic (A,) and basic (B) chains and a peptide 
chain connecting the A and B chains (C peptide) in a single polypeptide of 97 amino acids, and 
proinsulin that is formed after cleavage of 23 residues of C peptide and formation of disulphide 
linkage between the A and B chains in the RER. After the proinsulin in transfered to the Golgi 
apparatus, C-pepetide is removed in the secretory granules and proinsulin and C-peptide are 
both stored in the cytosol (Hadley, 1996). They are released from granules at the same time 
and therefore C-peptide can be measured to monitor insulin endogenous production in 
patients subjected to insulin therapy (Swenson and Reece, 2002). Ultimately insulin consists of 
two peptide chains, A and B, composed of 21 and 30 amino acids respectively and linked by two 
disulphide bridges.  There are only minor differences in chemical structures of insulin secreted 
by different mammalians, that don’t influence its biological effects if administered in 
heterologous species but can cause antigenic responses after prolonged treatments (Ganong, 
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1991). For instance, threonine located in position 30 of the B chain in human insulin is replaced 
with alanine in bovine insulin (Hsu and Crump, 1989).  
 
3.1.4 The process of insulin secretion: 
Once insulin is synthesized, it is secreted in two different phases after glucose enters the β cells. 
As for the first phase, preformed insulin release is triggered rapidly within 3-5 minutes since 
sudden blood glucose increase. This initial hormone secretion can be tenfold but halves and last 
only for 5-10 minutes. The second phase is a slow release of newly formed vesicles that are 
triggered regardless of the glucose level (Guyton and Hall, 2000). It starts after 15 minutes and 
achieves a new plateau within 2-3 hours at a level that is usually higher than the initial phase. 
Insulin release occurs by exocytosis. After an increase of glucose in the blood, glucose is 
captured by his specific transport proteins, the insulin-independent GLUT-2, and flows into the 
cell. Next, glucose metabolism via glycolysis generates ATP inside the cell.  Elevated ATP/ADP 
ratio inhibits the ATP sensitive potassium ion channels on the β cells membrane, eventually 
leading to membranes depolarization and influx of extracellular Ca2+ ions through the voltage–
gated Calcium channels. Thus there is a transient vesicles fusion to the cell membrane and their 
insulin content is excreted in the bloodstream (Kumar et al., 2005; Guyton and Hall, 2006). 
 
3.1.5 Insulin receptors and tissues signal trasduction:  
The insulin transduction pathway is an important biochemical pathway beginning at the cellular 
level affecting homeostasis. This insulin signal transduction pathway is composed of trigger 
mechanisms that serve as signals throughout the cell. The insulin receptor is a dimer of 2 α and 
2 β subunits. The α subunit is located on surface of the cell and the insulin binds to it at the cell 
membrane, whereas the β subunit is located inside the cell and has a tyrosine kinase domain 
(Kahn, 1994). The α subunit acts as an enzyme that activates insulin functions and after insulin 
attachment causes autophosphorylation by ATP of the β subunit, which triggers tyrosine kinase 
activity in the cell. Thus, the hormone-receptor complex is internalized and intracellular 
secondary messengers are propagated in a chain reaction through enzymes phosphorylation 
and dephosphorylation cascades.  These messengers are specific for the final biological effects 
of insulin, which for simplicity can be distinguished in mitogenic and metabolic functions. For 
instance, phosphorylation and activation of guanosine triphosphate (Ras complex) and 
Mitogen-activated protein kinase (MAPK) are responsible for expressing mitogenic functions 
like cell growth, proliferation and gene expression; phosphorylation of phosphatidylinositol-3-
kinase (PI-3K) leads to crucial metabolic functions such as synthesis of lipids, proteins and 
glycogen. Most importantly, the PI-3K pathway leads to the distribution of glucose for 
important cell functions by binding to various glucose transporters (GLUT vesicles), and 
stimulates the translocation of vesicles containing GLUT 4 on cell membranes, thus increasing 
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the glucose entry rate inside cells (Kumar et al., 2006). Differences in possession of different 
type of GLUT implicate tissue dependency from insulin for uptake of glucose. For instance, 
GLUT 1 is predominant in brain, placenta, mammary gland and erythrocytes; GLUT 2 in the liver, 
kidney and pancreas; GLUT 3 in brain and placenta; GLUT 4 in adipose tissue and skeletal and 
heart muscle; and GLUT 5 in small intestine (DeFronzo et al., 1992). Among these, only GLUT 4 
needs of insulin for uptake of glucose. Instead the liver and mammary gland are not insulin-
sensitive organs. Therefore the effects of insulin are specific only for certain tissues: in 
particular insulin is very important in the uptake of glucose by muscle and adipose tissue (Zhou 
et al., 1999). 
 
3.1.6 Stimulus for insulin release in non-ruminants:  
There are several factors that can stimulate both insulin synthesis and release (Berne and Levy, 
1993). In non ruminants the most important stimulus is glucose elevation in the blood, followed 
by other nutrients like sugars (galactose, mannose, glyceraldehydes), aminoacids (especially 
arginine, leucine, alanine, lysine) free long-chain fatty acids and minerals (potassium and 
calcium). Regarding aminoacids, they have a different effect than glucose and can hardly 
increase insulin production if administered in absence of hyperglycaemia. Anyway, aminoacids 
are very powerful agonist of glucose in inducing insulin release under hyperglycaemic 
conditions. Furthermore numerous hormones can promote insulin activity, like gastrointestinal 
hormones (gastrine, secretine, cholecystokinin, pancreatic polypeptide, gastric inhibitory 
peptide and glucagone), in addition to drugs and β-adrenergic and parasympathetic activity 
(vagal stimuli and acetylcholine).   
On the other side, analogous but opposed factors can suppress insulin release: decreased 
glucose level in the blood, gastrointestinal hormones (galanin, somatostatin, pancreastatin), 
sympathetic and α-adrenergic stimuli (catecholamines) and other specific compounds (e.g. IL-1, 
PGF2-α). Even some psychic or sensory perceptions, like the view of food or its presence in the 
mouth, can anticipate and strengthen the last direct action of glucose on endocrine pancreas. 
These factors can either induce insulin release via vagal stimulation of hypothalamic hunger 
center (ventro-lateral hypothalamus) or suppress its release via sympathetic nervous system 
and ventro-medial hypothalamus centers (Aguggini et al., 2000). All the CNS neurons are 
permeable to glucose with no need for insulin mediation, except for the ventro-medial 
hypothalamus. Still later the presence of ingesta in the gastrointestinal tract, and their quality, 
will further promote insulin secretion through gastrointestinal hormones and vagal tone.  
 
3.1.7 Stimulus for insulin release in ruminants: 
Owing to distinct differences in nutrient metabolism between ruminants and non-ruminants, 
the magnitude of insulin secretion in response to nutrients varies greatly (Brockman and 
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Laarveld, 1986). It is well known that fatty acids (FA) with 3- to 8-carbon chains increase insulin 
secretion in ruminants (Horino et al., 1968). Moreover, valerate and butyrate were reported to 
be responsible for maximum elevation of plasma insulin and were more potent for insulin 
secretion than glucose in ruminants, but failed to stimulate insulin secretion in rabbits and pigs.  
However a certain haematic glucose concentration is necessary in ruminants to meet the basal 
requirements and thoroughly use fatty acids, preventing the formation of keton bodies. Given 
to low plasma glucose levels, ketonaemia is very frequent in ruminants. Thereby the insulin 
secretion is mostly regulated by haematic VFA and keton bodies because they are the most 
abundant energetic source and can easily enter the haemato-encephalic barrier and they can 
be utilized by brain (Aguggini et al., 2000). In conclusion, glucose has a secondary role in insulin 
control in ruminants.    
 
3.1.8 The role of insulin in glucose metabolism: 
Insulin forces entry of glucose into cells and its storage in the form of glycogen, most 
prominently in muscle and adipose tissue, via modification of action of numerous enzymes. 
Inward movement of glucose is speeded up by two mechanisms: an increased rate of exocytosis 
and decreased endocytosis of GLUT 2 in hepatocytes, and stimulation of glucokinase activity, 
which phosphorylates glucose to glucose 6-phosphate (G6P) (Katzung, 1995). The rapid glucose 
phosphorylation tends to keep a low intracellular glucose concentration. Thus, the gradient of 
glucose is normally directed inward but, again, insulin can greatly speed up this process. In the 
same way, insulin facilitates entry of glucose into adipose tissue through GLUT 4, where glucose 
is then oxidized for esterification of free FA during lipogenesis. This phenomenon is highly 
specific and mostly limited to glucose and other few similar sugars, which can compete for their 
transportation (Ganong, 1991). At the same time both in the liver and muscle, insulin can 
stimulate glycogenesis and glycolysis by following similar pathways except for uptake of 
glucose. The liver utilizes GLUT 2, whereas muscle utilizes GLUT 4. Glycolisis is stimulated by 
insulin through activation of phosphofructokinase and pyruvate kinase, which direct the flow of 
glucose towards pyruvate and lactate (Berne and Levy, 1993). Glycogen synthesis is mediated 
by the action of glycogen synthase. In ruminants, insulin also stimulates glycogen synthase, but 
glucokinase activity is little or absent in the liver (Brockman and Laarveld, 1986). Instead, 
hexokinase is involved in the uptake of glucose in the ruminant liver (Brockman, 1984). 
However, hexokinase has a lower affinity for glucose compared with glucokinase (Berne and 
Levy, 1993). For this reason, the ruminant liver normally takes up only small amounts of 
glucose. Insulin then suppresses glucose production from non-sugar substrates by inhibiting key 
enzymes (e.g. pyruvate carboxylase and phosphoenolpyruvate carboxykinase) for 
gluconeogenesis (O’Brien and Granner, 1990) and glycogen phosphorylase for glycogenolysis. 
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3.1.9 The role of insulin in lipid metabolism: 
In adipose tissue and muscle, insulin enhances FA esterification and triglyceride (TG) synthesis 
by providing FA substrates inside cells. In the small vessels of the adipose tissue, insulin 
stimulates lipoprotein-lipases (LPL) and TG division and lets free FA enter into adipocytes. The 
free FA is re-esterified with glycerophosphate, derived either from glycolysis, glycerol or other 
FA. Precursors for lipogenesis are different between ruminants and non ruminants: glucose is 
the major precursor for lipogenesis in adipose tissue of non-ruminants, whereas acetate is the 
major precursor in ruminants (Prior and Scott, 1980). Also in the liver, insulin stimulates 
lipogenesis and inhibits ketogenesis (Brockman, 1978, 1979). Further, NEFA mobilized from 
adipose tissue is the primary source of hepatic lipogenesis in ruminants (Emery et al., 1992). 
Nevertheless, unlike in non-ruminants, the ruminant liver is not a primary organ for lipogenesis 
(Ingle et al., 1972). In any case, oxidation of glucose is indispensable to generate NADPH2 and α-
glycerophosphate for FA synthesis from lactate and acetate in ruminants (Prior and Scott, 
1980). The effect of insulin is decisive on carboxylation of mitochondrial acetyl-CoA generated 
by glycolysis in non-ruminants or directly derived from acetate in ruminants. Thanks to insulin 
intervention, acetyl-CoA is then converted into malonyl-CoA by acetil-CoA carboxylase 
(Brockman, 1978, 1979). Malonyl-coA represents the primary step in FA formation. 
Additionally, insulin can inhibit lipolysis by slowing down the activity of lipase and protein 
kinase A and lowering the level of cAMP. Moreover, insulin control of lipogenesis and lypolysis 
in adipose tissue guarantees lower circulating non-esterified fatty acids (NEFA), reduces their 
uptake from the liver and improve peripheral tissue ketone utilization. In summary, it is clear 
that insulin mainly favorites the utilization of carbohydrates as energetic font. Instead, it 
depresses fat usage by tissues, except for CNS.  
 
3.1.10 The role of insulin in the protein and mineral metabolism: 
Insulin intervenes on protein metabolism through activation of amino acids uptake inside the 
cell, decreased proteolysis and breakdown of proteins inside the lysosomes, increase of special 
DNA sequences transcription, mRNA translation and protein synthesis. The enzymes 
responsible for carbohydrates, lipids and proteins storage are the most induced by insulin 
activities. Owing to her anabolic influence, insulin is even concerned in the growth process and 
cooperates with other anabolic hormones like somatotropine (growth hormone, GH) and 
androgens in a different but synergic manner (Guyton and Hall, 2000). For instance, each 
hormone has a stronger capacity for the regulation of certain amino acids uptake by cells. In the 
case of insulin, it promotes valine, leucine, thysorine and phenylalanine transfer.   
As to mineral metabolism, insulin facilitates the entry of potassium ions into the muscle and 
miocardic cells because it enhances the activity of the Na
+
-K
+
 ATPase pump in the cell 
membranes. The consequence is a decrease of potassium in the extracellular fluid and cells 
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iperpolarization. On the contrary, potassium ions depletion, like in patients affected by primary 
iperaldosteronism, tends to reduce insulin secretion and develop diabetic symptoms.  
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3.2 Insulin resistance phenomenon: 
Insulin resistance is a generic term which describes “the state where a physiological level of 
insulin produces a less than normal biological response” (Kahn, 1978). This may be due to 
defects located either at the pre-receptor level, or at the receptor and post-receptor levels. 
Actually insulin resistance can be sketchily defined as insulin responsiveness or insulin 
sensitivity. The former is evaluated as the response of insulin to glucose, the latter as tissue 
responsiveness to insulin. First, pre-receptor level defects include decreased insulin production, 
increased insulin degradation, or both. Secondary, the molecular mechanisms in defects at the 
receptor level include decreased number of receptors and decreased binding affinity. 
Ultimately, in post-receptor defects the intracellular signaling steps of insulin action and 
translocation of GLUT may be impaired. Kahn (1978) has stated that, in general, 
hypoinsulinaemia is a common feature in pre-receptor defects; reduced insulin responsiveness 
is typical of receptor level defects; and reduced insulin sensitivity is linked to post-receptor 
defects. The consequence of these alterations is a multi-factorial complex of symptoms, such as 
hyperglicaemia, ketonaemia and ketosis, metabolic acidosis, glucosuria, diuresis, dehydration, 
exc., (McCance and Huether, 1994) that is common to many physio-pathological events in 
humans and all domestic animals, included ruminants. In humans, these disorders are well 
characterized into different types of diabetes. In ruminants, they are also seen in ketosis 
syndrome and haepatic lipidosis during particular stages of productive life (Drackley et al., 
1992). In all cases, this syndrome recognizes similar aetiological and pathogenetical factors 
(Hayirli, 2006).  
 
3.2.1 Risk factors of insulin resistance syndrome: 
Hereafter, I will focus on description of disorders and factors that are relevant for ruminant 
animals, and particularly in high producing dairy cows. 
 
Gestation: 
Insulin resistance and a decrease in peripheral tissues sensitivity to insulin are commonly 
observed during late gestation (Hay et al., 1988; Petterson et al., 1994). In this phase, fetal 
glucose uptake is approximately 50% of glucose production in ewes (Prior and Christenson, 
1978) and insulin-mediated uptake of glucose by skeletal muscle and adipose tissues and 
inhibition of lipolysis are decreased (Schlumbohm et al., 1997). Uptake of glucose and numbers 
of GLUT 4 in heart muscle and white and brown adipose tissues were lower in pregnant rats 
compared to non-pregnant rats (Nieuwenhuizen et al., 1998). The glucose transfer from 
placenta to fetus is dependent on the difference of concentration of this molecule between 
maternal and fetal plasma (Simmons et al., 1979) and is mediated by specific transport proteins 
GLUT-1 and GLUT-3. The number of these carriers increases along the advance of pregnancy in 
 12 
 
order to enhance the transfer of glucose across placenta (Hay, 1995). Reduced insulin 
sensitivity by peripheral tissues during late pregnancy assures adequate transfer of glucose 
from dam to fetus as an insulin-independent process. This mechanism is affected by increased 
serum concentrations of the hormones estradiol, progesterone and prolactin during late 
gestation. It appears that oestrogen enhances the action of insulin during non-pregnancy and 
lactation and progesterone suppresses insulin actions during late pregnancy. This was 
suggested by Ryan and Enns investigation on the effects of these hormones on insulin action in 
isolated cells from adipose tissue of pregnant, non-pregnant, and virgin rats (1988). Addition of 
estradiol to culture medium increased maximum insulin binding; addition of progesterone 
decreased glucose transport and maximum insulin binding; and addition of prolactin and 
placental lactogen decreased glucose transport without changing maximum insulin binding. 
Besides, maternal insulin concentration tends to decrease towards the end of gestation and is 
inversely proportional to placental lactogen levels in ewes (Blom et al., 1976; Vernon et al., 
1981). Otherwise, the insulin response to a glucose load is significantly lowered in these 
pregnant animals (Van der Walt et al., 1980). Lomax and colleagues hypothesized that the 
decline in insulinemia in the last third of gestation in ruminants might be linked to a reduced 
capability of pancreas to react to insulinotropic agents like glucose (1979).  
 
Nutrition - energy density of diet:  
Malnutrition and feed restriction reduces the glucoregulatory actions of insulin. Feed restriction 
results in hypoinsulinaemia in donkeys (Forhead and Dobson, 1997) and a decrease in islet 
numbers and islet size, which may cause lower insulin secretion (Tse et al., 1998). Further, an 
experiment conducted in rats by Reis and colleagues (1997), reported that basal serum insulin 
and plasma glucose concentrations and glucose clearance rate were lower in malnourished rats 
than in well-nourished rats during the oral GTT. Moreover, insulin secretory response to 
glucose addition to cell media containing pancreas islets isolated from malnourished rats was 
lower compared to those isolated from well-nourished rats. Similarly, in dairy cattle, decreased 
plasma insulin prior to parturition and in the first weeks after calving may reflect regression of 
the pancreas as a result of depression in DMI. Inadequate feeding during the dry period can 
cause a variety of problems in the postparturient cow, including susceptibility to infections, 
infertility, and adverse effects on milk production. A common recommendation is that the dairy 
producer should try to maximize DMI intake in close-up dry cows, to prepare the cow for a 
higher feed intake immediately after calving and, in turn, reduce metabolic disorders 
(Grummer, 1995). 
In a study of 2003, Holtenius and colleagues reported that plasma glucose disappearance rate, 
and thereby the effectiveness and concentration of insulin, was related to feeding regimen 
offered during the prefresh transition period of cows fed to consume 6, 9 and 14.5 kg DM, 
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providing 71 (Low energy diet, L), 106 (Medium energy diet, M), or 177 MJ (High energy diet, H) 
of metabolizable energy (ME) per day. The diets provided in average 75, 110, and 178% of the 
energy requirements for maintenance and pregnancy according to the Swedish feeding 
recommendations (Spӧrndly, 1999). These diets were introduced when the cows were dried off 
from the previous lactation, at least 8 wk before expected parturition. After parturition all cows 
were fed another total mixed ration ad libitum. They found a markedly higher plasma insulin 
concentration and a lower glucose clearance rate in prepartum H cows, compared to M and L 
cows. They suggested that this could reflect a prepartum positive energy balance (EB) but also a 
greater insulin resistance. Also, there were no differences in DMI in early lactation, but during 
wk 6 to 12 postpartum DMI was lower among H cows, which was linked to a prolonged 
negative energy balance in this group. At the same time body weight loss was greatest in these 
cows and mainly occurred in lactation weeks 1 to 4, whereas the milk yield did not differ 
between treatments (Agenӓs et al., 2003). 
However, the magnitude and duration of malnutrition required to develop metabolic disorders 
in dairy cows are largely unknown. Relatively few studies have evaluated the effects of 
restricted feeding during the dry period on the health and metabolism of cattle. Cows subjected 
either to 30% feed restriction or reduction in DMI as they approach parturition are known to 
develop postpartum hepatic disturbances (Veenhuizen et al., 1991; Hayirli and Grummer, 
2004). In contrast, Holcomb et al. (2001) found no negative effects of restricted feeding except 
lower milk fat percentage in early lactation. Others believe that the low energy density of diets 
during the transition period is associated with improved DMI and energy balance (Douglas et 
al., 1998; Rabelo et al., 2003). On the other hand, overfeeding during the dry period might lead 
to appetite depression and an increased rate of health disorders and poor milk production 
(Rukkwamsuk et al., 1999).  
Most researchers have indicated that higher energy concentration of the diet precalving could 
improve voluntary intake, increase BW gain (VandeHaar et al., 1999; Dewhurst et al., 2000), and 
reduce the mobilization of adipose tissue and plasma NEFA concentrations (Ingvartsen and 
Andersen, 2000; Hayirli et al., 2002), which would improve the maternal regulation of 
physiological responses and enhance productive performance during the transition period 
(Contreras et al., 2004). Very recently (2012), Gao and colleagues ascertained that feeding 
lower energy diets to cows during the last three weeks prepartum had several significant 
effects both on the cow and her calf. They assigned 30 Holstein dairy cows to one of three diets 
during the last 21 days prior to calving. The diets consisted of a low energy group (net energy of 
lactation (NEL) = 5.25 MJ/kg of DM); medium energy group (NEL = 5.88 MJ/kg of DM); and high 
energy group (NEL = 6.48 MJ/kg of DM). Unfortunately, the authors did not report how much 
each cow was fed and estimate their energy intake. Cows fed the low energy diet had a large 
increase in plasma NEFA concentration from 21 to 7 days prepartum and their calf health was 
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profoundly affected. Their results suggest that maternal energy density during the last 21 d 
prepartum negatively affected growth, development, immunity, and antioxidant capability of 
neonatal calves and the energy balance of the mothers in the immediate postpartum period. 
 
Nutrition - fat feeding (hyper-insulinemia): 
During high-fat feeding lipid availability in muscle and liver and oxidation of fat are elevated but 
incomplete. Thus, fat feeding is accompanied by increased plasma NEFA and ketons 
concentration. Ketogenic diets also cause acute hyper-insulinaemia and reduced insulin 
sensitivity. In general, hyper-insulinaemia downregulates insulin actions and signal trasduction 
at the receptor and postreceptor levels (Berne and Levy, 1993; Sebokova et al., 1995). In fact, 
hyper-insulinaemia jeopardizes the ability of insulin to suppress hepatic glucose production in 
the liver (Oakes et al., 1997) and impair glucose uptake by peripheral tissues. Glucose uptake is 
limited by alterations of cell membrane fluidity, reduced number of GLUT 4 and decreased 
glucokinase activity in the liver and muscle. These mechanisms were confirmed in rats fed 
increasing dietary fat in vivo and in vitro experiments (Watari et al., 1988; Ruth and Kor, 1992; 
Ruth, 1992). High-fat diets were associated to important reduction in insulin binding. Insulin 
anti-lipolitic effect is also reduced and FA is released from adipose tissue (Sparks and Sparks, 
1995). The increased NEFA concentration in lipid induced insulin resistance was demonstrated 
in humans by Laville and colleagues (1995): insulin was not able to reduce plasma NEFA and 
lipid oxidation, following intravenous infusions of labeled glucose and palmitate compared to a 
control group. Furthermore, adverse effects of supplemental fat (more than 4%) on DMI of 
lactating dairy cattle are well documented. Mechanisms by which high level of supplemental fat 
adversely affect DMI include interference with acceptability of diet, reduced gut motility, 
decreased fermentation and degradation of fiber, and alteration of hormonal status (Devendra 
and Lewis, 1974; Palmquist and Jenkins, 1980; Allen, 2000). In 2002, Hayirli demonstrated a 
liner decrease in DMI in response to increasing level of dietary EE concentration and during the 
prefresh transition period. The extent of feed and energy intake depression is dependent upon 
fat type (Allen, 2000). Fat sources with more unsaturated fatty acids reduce intake to the 
greatest extent and fatty acids that are highly saturated have less effect. 
 
Obesity and fat mobilization: 
A number of studies reveal that obesity is associated with increased likelihood of metabolic 
disturbances. Hyper-insulinaemia (McCann et al., 1986) and insulin resistance (Mahler, 1981; 
McCann and Reimers, 1985; Bergman et al., 1998) are common metabolic signs of obesity in 
non-ruminants and ruminants. Unlike obese non-ruminant species, obese ruminants have poor 
appetites (Garnsworthy and Topps 1982; Treacher et al., 1986; Hayirli et al., 2002b). Therefore, 
obesity in non-ruminants is associated with hyper-glycaemia and hyper-insulinaemia, whereas 
 15 
 
obesity in ruminants is associated with hypo-glycaemia and hypo-insulinaemia. Feeding 
behavior has been linked to ATP concentration within cells in the liver with satiety occurring as 
fuels are oxidized and ATP is produced, and hunger occurring as oxidation decreases and ATP is 
depleted (Allen, 2000). According to the Hepatic Oxidation Theory (HOT), formulated by Allen 
and colleagues (2000; 2005), it is important to realize that “the pattern of oxidation of fuels 
(minute to minute) is what affects feeding behavior because the amount of oxidation over 
longer periods of time (hours or days) is relatively constant”. Because fatty acids are readily 
oxidized in the liver, the supply of NEFA from mobilization of body fat reserves likely suppresses 
feed intake in the transition period. As a consequence of obesity, the degree of fat mobilization 
is dependent upon the amount of fat reserves available for mobilization as well as changes in 
insulin concentration, tissue sensitivity to insulin, and stress. Cows with excessive body 
condition generally mobilize fat very rapidly through transition because their tissues are more 
insulin resistant and they have greater fat stores to mobilize. Recent research indicates that 
allowing cows to consume more energy than required during the far-off dry period results in 
increased NEFA concentrations in early lactation (Holtenius et al., 2003). Hormones released 
during stress increase fat mobilization, elevating plasma NEFA concentration further. Free FA 
competes with glucose for utilization by insulin-sensitive tissues (Boden, 1977; Koopmans et al., 
1996) and has toxic effects on peripheral tissues (Spector and Fletcher, 1978). Noshiro and 
colleagues (1997) tested insulin action on insulin-sensitive lean rats and insulin-resistant obese 
Zucker rats. The adverse effect of NEFA concentration was more pronounced in obese rats than 
in lean rats. The adverse effect of elevated NEFA concentration on adipose tissue insulin 
sensitivity was also demonstrated (VanEpps-Fung and colleagues, 1997; Bergman and 
Mittelman, 1998). In summary, elevated NEFA concentration causes inhibition of insulin-
stimulated glucose uptake by peripheral tissues, decreases the number and translocation of 
GLUT 4, and disturbs intracellular insulin signalling pathways in the liver and peripheral tissues 
with an increased risk for receptor downregulation (Garvey et al., 1986).  
 
Genetics: 
Until recently, general dairy cow breeding policy has resulted in a cow that produces more milk 
and has a greater propensity to mobilize body fat in early lactation (Buckley et al., 2000; Roche 
et al., 2006; McCarthy et al., 2007). Intensively selected cows in early lactation experience a 
subsequent failure to replenish body energy stores. This challenge has also been associated 
with reduced reproductive performance (Beam and Butler, 1999; Buckley et al., 2003; Roche et 
al., 2007). Low insulin levels are associated genotypically (Gutierrez et al., 2006) and 
phenotypically (Ingvartsen and Friggens, 2005) with high milk yield. Although insulin has no 
direct effects on galactopoiesis, low insulin decreases the uptake of glucose by insulin-sensitive 
tissues, such as skeletal muscles, and enhances glucose availability for the mammary gland, 
 16 
 
which is insulin-insensitive (Zhao et al., 1996; Nishimoto et al., 2006; van Knegsel et al., 2007). 
Therefore, insulin is a very interesting candidate molecule concerning the paradox between 
yield, metabolic diseases, and reproductive performance. There is further evidence of a 
tendency for higher body weight in cows with genetic merit for low milk fat content compared 
to high fat content (Agenӓs et al., 2003). Cows of North American (NA) and New Zealand (NZ) 
origin represent 2 strains of high and low genetic merit for milk production (Roche et al., 2006). 
NA cows produce more milk, have a greater propensity to mobilize body condition in early 
lactation and partition less energy to improving body condition in mid and late lactation (Horan 
et al., 2005; Roche et al., 2006; Mc-Carthy et al., 2007; Macdonald et al., 2008). These strain 
differences should be due, at least in part, to an altered response of tissues to insulin and a 
resultant increased nutrient supply, particularly of glucose and fatty acids, to the mammary 
gland to support milk production. Cows of NZ origin fed a TMR have a greater insulin response 
to a glucose challenge than either NZ cows grazing pasture or NA cows fed TMR or pasture 
(Chagas et al., 2003), indicating a potential interaction between strain of Holstein-Friesian (HF) 
cow and diet on insulin resistance in early lactation. These data are consistent with the 
hypothesis that insulin dynamics may be involved in the effect of genetic strain, nutrition, or 
both on nutrient partitioning (Chagas et al., 2007a). In 2009, Chagas and colleagues confirmed 
that differences in milk production between NA and NZ cows in early lactation can be explained 
by a greater glucose fractional turnover rate in NZ cows compared with those of NA origin. In 
2009, further data by Kay and colleagues from New Zeland supported the hypothesis for 
potential strain differences in recoupling of the somatotropic axis, insulin resistance, and 
energy partitioning, and may help explain the physiology behind the previously reported 
greater milk production and body condition score loss in NA HF. They offered 0, 3, or 6 kg of 
concentrate DM/cow per day for an extended lactation to fifty-six genetically divergent NZ and 
NA HF cows grazing pasture (605 ± 8.3 d in milk; mean ± standard error of the mean). During 
early lactation, NEFA and GH concentrations were greater and IGF-I concentrations were less, 
and increased at a slower rate in NA HF. During the extended lactation period, NA HF had 
greater NEFA and GH concentrations; there were strain × diet interactions for insulin and leptin, 
and a tendency for a strain × diet interaction for glucose. These interactions were primarily due 
to greater plasma insulin, leptin, and glucose concentrations in the NZ HF fed 6 kg of 
concentrate DM/cow per day, a result of excessive body condition in this treatment. In a similar 
study conducted in New Zeland (White et al., 2012), expression of pyruvate carboxylase (PC) 
mRNA in liver biopsies from 27 NZ and 27 NA HF cows was monitored at 0, +1, and +4 wk 
relative to calving.  Pyruvate carboxylase is a rate-limiting enzyme for hepatic gluconeogenesis. 
The responses of NZ and NA cows to the transition to lactation and concentrate 
supplementation appeared to be similar; however, NZ cattle had a higher basal expression of 
PC. In the same recent years, McCarthy et al. (2009) compared the hepatic expression of genes 
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of the growth hormone (GH)-IGF (or somatotropic) axis in the NA HF and the NZ HF strains of 
dairy cow at early and mid lactation. They found that early-lactation adaptations to negative 
energy balance may have more severe effects in the NA strain compared with the NZ strain 
because the NZ strain had greater expression of IGF-1. In the immediate postpartum period, the 
somatotropic axis in the liver becomes uncoupled, whereby elevated plasma GH concentrations 
fail to stimulate an increase in hepatic IGF-1 synthesis (Thissen et al., 1994; Fenwick et al., 2008; 
Lucy, 2008). IGF-1 plays a critical role in stimulating the anabolic and mitogenic activity of GH in 
various tissues (Laron, 2001). Numerous reports have suggested that nutritionally compromised 
cows have reduced systemic concentrations of insulin and IGF-1 (Patton et al., 2006; Lucy, 
2008). It has been reported that irreversible glucose loss leads to some degree of uncoupling of 
the somatotropic axis as plasma concentrations of IGF-1 decline concomitantly with a reduction 
in hepatic mRNA abundance of IGF-1 and GH receptor (GHR; Meier et al., 2008). Previous 
studies have demonstrated that systemic concentrations of the metabolic hormone IGF-1 in 
early lactation are positively associated with the subsequent calving-to-service interval and 
ultimately the pregnancy outcome in dairy cattle (Taylor et al., 2004; Patton et al., 2007; 
Wathes et al., 2007). McCarthy’s results were consistent with other recent authors’ findings of 
greater IGF-1 plasma concentrations in NZ HF during the post-transition period (30 to 90 d post-
calving; Patton et al., 2008).  
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3.3 Physiological metabolic modifications in the transition dairy cow: 
The transition from late gestation to early lactation is a period of dramatic physiological and 
metabolic adaptation for the dairy cow. During late gestation the nutritional demands of the 
fetus and uterus increase exponentially, while intake is often reduced by the endocrine changes 
that induce parturition and parturition itself. Other several factors which can impact on intake 
have been investigated and discussed for many decades (Ingvarsten and Andersen, 2000). 
Factors affecting and regulating DMI of lactating dairy cattle are numerous, complex, and span 
from cellular to environmental conditions (Forbes, 1996; Roseler et al., 1997a, b; Allen, 2000). 
These factors can be categorized broadly as animal factors (i.e., age, body condition, breed, 
physiological stage, and milk yield level), dietary factors (i.e., ingredient and nutrient 
compositions of diets and physical and agronomic characteristics of feed stuffs), managerial 
factors (i.e., production, feeding, and housing systems), and climatic factors (i.e., temperature, 
humidity, and wind) (NRC 1987). Factors affecting DMI and depression in DMI during the 
prefresh transition period are largely unknown. It is possible that factors affecting DMI in 
lactating dairy cattle and other ruminants also influence DMI in prefresh transition dairy cattle 
(Hayirli et al. 2002).  
After calving, increases in nutrient requirements for milk synthesis outpace increases in intake 
(Bell, 1995). For the dairy cow, the most severe nutritional imbalances typically occur during 
transition (Grummer, 1995). Development of negative energy balance prior to parturition and 
its continuation through early lactation are due to significant DMI depression (Bertics et al., 
1992; Hayirli et al., 2002b) and the lag time between peaks of intake and milk yield, respectively 
(Baird, 1981; Grummer, 1995). Dairy cattle loose body weight (BW) and body condition score 
(BCS) to compensate for the energy deficit (Coppock, 1985). Lactogenesis is accompanied by 
alterations of metabolism, which include increased lipolysis and decreased lipogenesis in 
adipose tissue, decreased glycogenesis and increased gluconeogenesis and glycogenolysis in the 
liver, decreased use of glucose and increased use of lipid as energy sources by body tissues, and 
increased mobilization of protein reserves from muscle tissue (Bauman and Currie, 1980; Collier 
et al., 1984; Reynolds et al., 2003). Several euglycemic clamp studies (Debrass et al., 1989; Prior 
and Christenson, 1978; Sano et al., 1991) ascertained that insulin resistance begins before 
parturition and continues during early lactation. Thus, during the periparturient period, insulin 
resistance may be an important factor in the initiation of catabolic activities (Holstenius, 1993). 
Milk synthesis is drawn by glucose availability for lactose production. For a cow producing 35 kg 
of milk per day with 4.9% lactose, about 2.9 kg glucose is used for lactose secretion in the 
mammary gland, of which 2.7 kg is provided via gluconeogenesis in the liver (Young, 1976). 
Propionate accounts for most of glucose released from the liver (about 70%) during the final 
two weeks of gestation (Reynolds et al., 2003).  
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Although propionate is very rapidly taken up by the liver, when it is absorbed faster than it can 
be utilized to produce glucose, it will likely be oxidized, generating ATP and a satiety signal to 
the brain. The capacity of the liver to produce glucose is affected by glucose demand because 
limiting enzymes in the liver are up-regulated to meet the need. Because of this, propionate is 
less likely to be oxidized (and decrease feed intake) at peak lactation when glucose demand is 
high, than in late lactation when glucose demand is lower. Although propionate might be 
expected to have little effect on feed intake of fresh cows because they have high glucose 
demand, decreasing oxidation of propionate per se, propionate also stimulates oxidation of 
acetyl CoA. Fresh cows have a large supply of acetyl CoA in the liver from partial oxidation of 
NEFA. Some acetyl CoA is exported as ketones, but it is also readily oxidized when propionate is 
taken up by the liver, quickly generating ATP and a satiety signal (Allen and Bradford, 2006). 
This is an apparent contradiction: propionate is a primary fuel used to produce glucose, which is 
needed to increase insulin and decrease NEFA, thereby alleviating the depression in feed intake 
by NEFA oxidation in fresh cows, but propionate itself suppresses feed intake by stimulating 
oxidation of acetyl CoA in fresh cows. That is, the metabolic profile during early lactation 
includes low concentrations of serum insulin, plasma glucose and liver glycogen and high 
concentrations of serum glucagon, adrenaline and GH, plasma β-hydroxybutyrate (BHB) and 
NEFA, and liver triglycerides (Herbein et al., 1985; Vazquez-Anon et al., 1994). These changes 
predispose dairy cows to hepatic lipidosis and ketosis. This metabolic pattern is also reported in 
cases of induced or spontaneous hepatic lipidosis and ketosis (DeBoer et al., 1985; Veenhuizen 
et al., 1991; Drackley et al., 1992). Lower mitochondrial glycerol-phosphate acyltransferase 
activity (Rukkwamsuk et al., 1998, 1999b) diverts FA from esterification into β-oxidation in 
order to protect the hepatocytes against further accumulation of TG during NEB (Bruss, 1993). 
Because liver contributes a small fraction of total body fat synthesis (Ingle et al., 1972), FA 
mobilized from adipose tissue is the primary sources of hepatic TG in ruminants (Emery et al., 
1992; Bruss, 1993; Grummer, 1993). NEFA are either directly transported to mammary gland 
(Annison et al., 1967) or are taken up by the liver in relation to their concentration in plasma 
(Heimberg and Wilcox, 1972). In the liver, FA is re-esterified to TG that can be stored or 
exported as VLDL, or FA is oxidized either completely to carbon dioxide in tricarboxylic acid 
(TCA) cycle or incompletely to ketone bodies. When the export of TG as VLDL from the liver 
cannot keep pace with increased NEFA uptake and TG synthesis by the liver, hepatic lipidosis 
becomes significant (Grummer, 1993). 
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3.4 Post-partum metabolic disorders related to energetic metabolism:  
Hepatic lipidosis and ketosis occur as a result of inability to keep pace with homeorhetic 
changes during the periparturient period, as previously described, and are common lipid-
related metabolic disorders in the fresh high producing dairy cow (Herdt et al., 1983, 1988; 
DeBoer et al., 1985; Veenhuizen et al., 1991; Drackley et al., 1992; Grummer, 1993; Vazquez-
Anon et al., 1994). The aetiologies of hepatic lipidosis and ketosis are similar and liver function 
is impaired in both cases (Strang et al., 1998; Zhu et al., 2000).  
Hepatic lipidosis refers to accumulation of lipids in hepatocytes (Pearson and Maas, 1990). 
Many cows experience hepatic lipidosis and ketosis of varying degrees of severity during the 
periparturient period (Grummer, 1993). The severity of hepatic lipidosis is related to the degree 
of mobilization of adipose tissue fat reserves (Roberts et al., 1981). Hepatic lipidosis may 
compromise production (Gerloff et al., 1986a), immune function (Ropstad et al., 1989; Kaneene 
et al., 1997), and fertility (Reid et al., 1979a,b) and increases the likelihood of ketosis (Drackley 
et al., 1992). Major factors causing hepatic lipidosis include increased supply of long-chain FA 
by adipose tissues and diet, impairment of TG incorporation into VLDL, and defects in VLDL 
transport (Gruffat et al., 1996).  
Ketosis occurs after hepatic lipidosis in high-producing dairy cows (Reid, 1980) and is 
characterized by hypo-phagia, decreased milk production, increased BW and BCS loss, lethargy 
or hyper-excitability, hypo-glycaemia, hypo-insulinaemia, hype-rketonaemia, hyper-lipidaemia, 
and depleted hepatic glycogen (Veenhuizen et al., 1991; Drackley et al., 1992). Moreover, liver 
TG concentration is negatively correlated with plasma glucose and serum insulin concentrations 
and positively correlated with plasma NEFA and BHBA concentrations (Studer et al., 1993). 
Brockman (1979) summarized direct and indirect antiketogenic effects of insulin, which include 
decreasing liver NEFA uptake through stimulating lipogenesis and inhibiting lipolysis in adipose 
tissue; enhancing peripheral tissue ketone utilization; and altering enzyme activities and 
availability of substrates that are involved in ketogenesis in the liver. The impact of insulin on 
enhancing utilization of BHB and acetoacetate by extra hepatic tissues was demonstrated in 
normal and alloxan induced diabetic sheep (Jarret et al. 1976). Insulin decreases activity of 
carnitine palmitoyl transferase-I (CPT-I) and increases affinity of CPT-I for malonyl-CoA 
(Grantham and Zammit 1988). Moreover, insulin inhibitory effect on ketogenesis is also related 
to its stimulatory effect on activity of acetyl-CoA carboxylase and formation of malonyl-CoA 
that inhibits activity of CPT I (Zammit 1981, 1990, 1996).  
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3.4.1 Relationship between insulin resistance and immunosuppression:  
Metabolic disorders (milk fever, displaced abomasum, ketosis, and fatty liver syndrome) and 
mammary gland (mastitis and mammary gland edema) and reproductive diseases (veterinary 
assisted dystocia, retained placenta, and metritis) seemingly occur as a complex during the 
periparturient period (Curtis et al., 1985; Correa et al., 1990; Erb and Grohn, 1998). Moreover, 
these health problems compromise lifetime milk yield and reproductive efficiency (Erb et al., 
1985; Deluyker et al., 1991; Rajala-Schultz et al., 1999). Elevated plasma ketones (greater than > 
20 mg BHB per deciliter) are a key element in the development of most disorders, other than 
the sole ketosis, because they compromise immune potency through suppressing mitogenic 
response of lymphocytes (Targowski et al., 1985; Franklin et al., 1991; Sato et al., 1994). There 
are also indications that reduced insulin sensitivity and low insulin result in lipolysis and 
elevated peripheral concentrations of NEFA during last weeks before calving, which, in turn, 
increase the risk of production diseases such as ketosis, retained fetal membranes (Dyk et al., 
1995), abomasal dislocation (Holtenius et al., 2000; Doll et al., 2009), and hepato-lipidosis and 
have a detrimental effect on granulosa cell function (Vanholder et al., 2005). Furthermore, 
various studies provide indications that inflammatory processes contribute to lipolysis, 
ketogenesis and hepatic disorders in dairy cows (Bionaz et al. 2007; Bradford et al. 2009, Hiss et 
al. 2009). It is also known that inflammatory diseases such as metritis and mastitis and 
inflammatory mechanism associated with subacute ruminal acidosis (Plaizier et al. 2008), very 
frequent in the fresh cow, possibly affects insulin response (Bigner et al. 1996) and reduce 
considerably insulin sensitivity (Kushibiki et al. 2000, 2001, 2003). In dairy cows currently there 
is little evidence that, compared to monogastrics suffering from the metabolic syndrome, 
chronic inflammatory processes in adipose tissue may contribute by means of adipokines and 
cytokines to the development of reduced insulin sensitivity (Saremi et al. 2011). Glucocorticoid 
treatment (Sternbauer et al. 1998, Kusenda et al. 2012) as well as endogenous cortisol release 
caused by stress challenges or pain (Rizk et al. 2012) affect glucose and fat metabolism due to 
reduced insulin sensitivity and depression of insulin mediated suppression of lipolysis. 
Therefore, the cow in the transition stage may enter a vicious cycle supported by concomitant 
alterations of energetic metabolism, diseases and inflammatory states that progressively 
influence and favour each other. 
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3.5 Nutritional strategies for preventing and limiting NEB and insulin resistance: 
Minimizing DMI depression or increasing nutrient density of the diet during the transition 
period would be an essential strategy to alleviate the severity of negative energy balance, 
maintain body reserves, increase nutrients available for rapid fetal growth, ease metabolic 
transition from pregnancy to lactation, and acclimate rumen microorganisms to lactation diets 
(Van Saun, 1991; Grummer, 1995; Nocek, 1995). Increasing dietary concentration of non-fibre 
carbohydrates during the last 21 days of gestation (NFC) (1.58–1.63 Mcal NEL/kg DM or 38–44% 
NFC) increases energy density of the diet by providing greater amounts of glucogenic 
precursors like propionate (Flipot et al., 1988; Minor et al., 1998; Dann et al., 1999; Rabelo et 
al., 2003) and maximizes DMI and energy intake by decreasing gut fill (Forbes, 1996). This 
feeding regimen stimulates the microbial flora (Forbes, 1996) and serum insulin secretion, 
which promotes papillae growth (Driksen et al., 1985). Increased growth of papillae enlarges 
the surface area and VFA absorptive capacity of the rumen epithelium (Driksen et al., 1985). In 
turn, this could prevent accumulation of VFA and normalize pH of the reticulo-ruminal fluid.  
In addition, factors affecting DMI during the prefresh transition are linked to limiting fat 
mobilization. Nutritional factors (e.g., feeding more energy as fermentable carbohydrates) that 
alleviate severity of hepatic lipidosis also affect ketogenesis (Hayirli and Grummer, 2004). The 
effects of this feeding regimen on the development of ketosis are mediated through insulin 
potential antiketogenic effects (Schultz, 1971; Schalm and Schultz, 1976). Despite a minimal 
energy density of the diet should be guaranteed in the prepartum phase, attention must be 
paid to avoid an excessively high speed of propionate production in the rumen. Because feed 
intake of fresh cows is likely controlled primarily by hepatic oxidation (HOT theory; Allen, 2000; 
Allen et al., 2005; Allen and Bradford, 2006; Allen and Bradford, 2010), it is necessary to 
manipulate the rate of propionate production to extend meal length, supplying other glucose 
precursors that stimulate oxidation of acetyl CoA to a lesser extent, and providing alternate 
energy sources for tissues to spare glucose  and elevate insulin concentrations, decrease fat 
mobilization and the period of time feed intake is suppressed by oxidation of NEFA in the liver.  
Diets with moderately high forage fiber concentrations might benefit fresh cows (Voelker 
Linton and Allen, 2007). Forage fiber increases rumen fill, decreasing the risk of abomasal 
displacement, and increases acetate production, sparing glucose utilization by extrahepatic 
tissues. While research is needed to evaluate effects of concentration and fermentability of 
starch on feed intake response, starch sources with moderate ruminal fermentability and high 
digestibility in the small intestine such as dry ground corn, compared to cracked corn and high 
moisture corn, will likely provide more glucose precursors by increasing feed intake. Hepatic 
oxidation of ketogenic amino acids can contribute to satiety according to HOT and urea 
production from excess ammonia produces a carbon skeleton that can be oxidized. However, 
greater dietary protein concentration can also increase feed intake by reducing propionate 
 23 
 
production. Increasing protein concentration could dilute diet starch concentration and 
decrease energy spilling by ruminal microbes, thus converting a greater fraction of fermented 
digesta into microbial cells and less into VFA. Formulating diets to maintain gut fill with 
ingredients that are retained in the rumen longer, and have moderate rates of fermentation 
and high ruminal digestibility will likely provide more energy over time when feed intake 
decreases at calving or from metabolic disorders or infectious disease. This will help maintain 
plasma glucose and prevent even more rapid mobilization of body reserves. 
Feed intake of dry cows must be limited by feeding diets with high forage NDF concentration. 
Diets with high concentrations of grain, non-forage fiber, and finely chopped forages fed 
through the transition period should be avoided. Increased amounts of ruminal digesta also 
decrease risk of displaced abomasum and increase buffering capacity, decreasing risk of 
acidosis. Some long fiber particles are necessary to form a mat and increase digesta retention in 
the rumen, but the length of cut, digestion characteristics and maturity of forage type can vary 
greatly and influence feed intake. Grass silage or hay is likely more beneficial than wheat straw 
because the fiber is more digestible and it provides energy for a longer time when feed intake 
decreases at calving (Beauchemin et al., 1994).  
Withal, mobilization of body fat during mid to late lactation must be prevented. It is advisable 
to feed a more filling, less fermentable diet as milk yield declines. As lactation progresses past 
mid lactation, faster propionate production by highly fermentable diet can depress feed intake. 
This will provide a more consistent supply of fuels, reducing insulin and partitioning more 
energy to milk rather than body condition.  
 
3.5.1 Diet Supplementation in the transition period: 
Supplementations of choline (Hartwell et al., 2000; Piepenbrink and Overton, 2003), inositol 
(Gerloff et al., 1986b) and methionine (Bertics and Grummer, 1999), which was intended to 
improve TG export by enhancing lipoprotein synthesis, failed to alleviate hepatic lipidosis in 
dairy cattle. Therefore, until factors impeding hepatic VLDL-TG export are identified, limiting fat 
mobilization from adipose tissue will play a key role in prevention of hepatic lipidosis. Studer 
and colleagues (1993) reported similar changes in transition dairy cows supplemented with 
propylene glycol. The antilipolytic effect of niacin supplementation during the periparturient 
period on alleviation of hepatic lipidosis is controversial. Minor and colleagues (1998) found a 
tendency for decreased liver TG, whereas Skaar and colleagues (1989) found no effect on 
hepatic lipidosis. Niacin likely needs to be supplemented at higher concentrations than 
currently recommended unless provided in a protected form. Chromium increases insulin 
sensitivity and supplemental chromium has been demonstrated to decrease plasma NEFA 
concentration and plasma glucose to serum insulin ratio in lactating dairy cows, no effect on 
hepatic lipidosis was reported in cows supplemented with chromium (Yang et al., 1996; Besong 
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et al., 2001; Hayirli et al., 2001; Pechova et al., 2002), which was intended to increase insulin 
action on extrahepatic tissues to inhibit lipolysis. However chromium supplements are not 
allowed for use in lactating dairy cattle diets by the European Union and other international 
food inspection agencies. Supplemental fat should not be fed through the transition period 
because it can depress feed intake by increasing the supply of fatty acids to be oxidized. An 
exception might be the use of supplemental conjugated linoleic acid (CLA) to suppress fat 
production in the mammary gland, benefiting fresh cows by sparing glucose. 
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3.6 Tests for measuring insulin resistance: 
Although several methods had been developed and validated to evaluate insulin sensitivity in 
human medicine, none of these methods can be universally used in all patients (Lais et al., 
2003). Some of these methods include: fasting plasma insulin, homeostatic model assessment, 
quantitative insulin sensitivity check index, glucose-to-insulin ratio, continuous infusion of 
glucose with model assessment, indices based on oral glucose tolerance test, insulin tolerance 
test, and the so called "gold standard" methods, the hyperinsulinemic euglycemic clamp and 
the frequently sampled-intravenous glucose tolerance test. Each method is characterized by 
specific procedures, cut-off values for defining insulin resistance, advantages and limitations, 
and suitability for use either in clinical practice or in research settings according to its 
handiness, accuracy and validity. In humans tests on insulin resistance are generally performed 
after an overnight fast to ensure a comparable and stable metabolic state regarding pancreatic 
baseline insulin secretion, glucose disposal and gluconeogenesis (Muniyappa et al. 2008; Borai 
et al. 2011). However, in contrast to monogastrics, ruminants are not in a fasting metabolic 
state after an overnight fast and additionally restricting access to feed will quickly result in 
increased lipolysis, ketogenesis and fat accumulation in hepatic tissue in early lactating dairy 
cows (Oikawa and Oetzel 2006, Quiroz-Rocha et al. 2010). In ruminants little information is 
available about the necessity and optimal duration of fasting and interpretation on test results 
yet. The hyperinsulinemic euglycaemic glucose clamp (HEC) technique and intravenous glucose 
tolerance test (IVGTT) are the most commonly used tests in research in dairy cows to evaluate 
insulin resistance or glucose intolerance.  
 
3.6.1 Hyperinsulinemic Euglycemic Glucose Clamp (HEC):  
The glucose clamp technique was originally developed by DeFronzo et al. (1979) and is seen as 
the reference standard for directly determining metabolic insulin sensitivity. In humans, after 
an overnight fast, during the clamp insulin is continuously infused resulting in a new steady 
state insulin concentration (SSIC). To maintain plasma glucose, parallel glucose is infused at 
varying infusion rates depending on results of frequently measured plasma glucose 
concentrations. Assuming that hepatic gluconeogenesis is almost completely suppressed by 
insulin infusions, the steady state glucose infusion rate (SSGIR) reflects glucose disposal to 
peripheral tissues, in particular muscle and adipose tissue. The ratio between SSGIR and SSIC 
reflects glucose disposal per unit of insulin (insulin sensitivity index, ISI). The HEC procedure 
allows the effects of insulin to be measured without the ensuing hypoglycemia. The amount of 
insulin required to achieve the maximum response indicates insulin responsiveness, whereas 
the amount of insulin required to reach the half-maximal response indicates insulin sensitivity 
(Kahn, 1978). Glucose infusion rate is equal to metabolic rate of glucose utilization (Sano et al., 
1991, 1993). The major limitations of HEC are that it is time consuming, labourious, very 
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expensive and requires an experienced operator to manage technical difficulties. Thus, use of 
HEC is restricted to experimental studies with limited number of animals.  
3.6.2 Frequently Sampled Intravenous Glucose Tolerance Test (IVGTT):  
The GTT is a more practical and cheaper test than the euglycaemic clamp technique for 
determining glucose intolerance. It is based on a bolus infusion of glucose and frequent blood 
sampling in short intervals to register glycemia, insulinemia and changes in blood NEFA 
concentrations. These paremeters give information on pancreatic insulin release, glucose 
disposal and insulin dependent suppression of blood NEFA concentrations (Grünberg et al., 
2011). In the GTT, basal and peak concentrations, plasma disappearance rate, half-life, time to 
reach basal concentration and ratio of plasma glucose to serum insulin are parameters for 
evaluation of glucose tolerance (Hayirli et al., 2001). Response measures to glucose challenges 
often involve area under the curve (AUC) calculations to estimate response over time after the 
challenge. Smaller glucose AUC might suggest greater glucose clearance and thus less insulin 
resistance. However, information obtained from GTT is not as easily interpreted as that 
generated from euglycaemic clamps. For instance, during the GTT, it is not known whether 
increased plasma glucose disappearance rate is due to increased glucose utilization or 
decreased insulin production. In this case, the molar ratio of serum insulin to glucose or the 
ratio of their disappearance rates is a better indicator of insulin resistance than plasma glucose 
disappearance rate alone (Subiyatno et al., 1996). Another limitation of IVGTT is hyperglycemia 
which may result in renal glucose losses and increased insulin independent glucose disposal to 
the mammary gland in lactating cows so that insulin dependent glucose utilization of peripheral 
tissues may be overestimated. Schoenberg and Overton (2011) combined the IVGTT with a 
single injection of insulin in low dose to estimate insulin dependent glucose disposal and 
suppression of blood NEFA. 
The GTT has been performed in various experiments in ruminants in the last years with 
particular attention to the few weeks prior to calving and immediately after. These studies have 
been used to show that insulin can alter plasma concentrations of several metabolites but, 
because of the low circulating concentration of insulin in early lactation, it may exert less 
control over metabolic processes in proximity of calving and under pathologic conditions.  For 
example, artificial hyperlipidemia was used in dairy cattle to mimic the increases in NEFA during 
late pregnancy, and successfully illustrated the negative effects that rising NEFA have on insulin 
signaling and glucose clearance during a GTT in the transition period (Pires et al., 2007). 
Bossaert and colleagues (2008) infused dextrose intravenously in 23 dairy cows at -14, 14 and 
42 d around calving to assess their  glucose-induced insulin responses at different time points 
relative to calving and to relate this to the metabolic status and the time of first ovulation. 
Furthermore, IV glucose infusion has been used to evaluate the profile of metabolic hormones 
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change, such as GH, Ghrelin, insulin and epinephrine, after a glucose challenge in ten 
multiparous dairy cows 35 d in milk (Roche et al., 2008). GTT was used in association to Insulin 
Tolerance Test (ITT), to determine the glucose-induced insulin responsiveness and insulin 
sensitivity in cows showing different forms of periparturient ketone pattern with and without 
puerperal metritis, and their interrelation with different metabolic and hormonal parameters in 
dairy cows (Kerestes et al., 2009). 31 Holstein cows were involved in this experiment between 
18 and 22 d before, and GTT was performed again on d 7 and 60-70 after calving. In a similar 
trial, the effects of periparturient propylene glycol supplementation on the same parameters 
and on the time of the first postpartum ovulation and pregnancy rates were analyzed through 
GTT and ITT (Kerestes Ph.D. dissertation, 2010).  
Likewise, additional researches have been carried out by use of GTT with the purpose of testing 
diets, nutrients and various therapeutic or other compounds effects on glucose metabolism. 
For instances, GTTs were conducted by Hayirli and colleagues (2001) on d 10 prepartum and d 
28 postpartum in 48 cows in order to study the effect of supplemental chromium as chromium-
methionine (Cr-Met) on production and metabolic parameters from 28 d before expected 
calving date through 28 d of lactation. Glucose curves in response to GTTs have been compared 
to those of Xylitol Tolerance Tests in four non-lactating cows, where xylitol appeared to cause 
similar secretion of insulin to that caused by glucose and have similar disappearance rate 
(Mizutani et al., 2003). Xylitol is a sugar alcohol that is often used for treatment of ketosis in 
dairy cattle in Japan. Therefore the experiment proved that xylitol had value for treatment of 
ketosis. IV treatments with 50% dextrose solution decreased phosphorus concentration in 
serum, compared with the control treatment and suppress BHB and NEFA concentrations for < 
12 hours in 24 clinically normal multiparous cows enrolled 5 to 10 d after parturition in the 
study (Wagner and Schimek, 2010). Recently, a study was completed in order to determine the 
effects of different dietary energy levels on responses to glucose and insulin challenges during 
the dry period in multiparous cows (Schoenberg et al., 2012). The insulinotropic effect of a high 
plane (HP) compared to a low plane (LP) of nutrition beginning 48 d before expected parturition 
was confirmed by the lower glucose AUC, than for those fed the LP diet, during GTTs (0.25 g of 
dextrose/kg of body weight (BW)) performed first on d 14 of treatment and then, following 24 h 
of feed removal, on d 17. In both nutrition planes, the AUC was higher during the GTT in the 
feed-deprived state than in the GTT during the fed state, suggesting slower clearance of glucose 
during negative energy balance either pre- or post-feed deprivation. Beyond this, after each 
GTT, cows were subjected to the HEC procedure, which attested prior GTT results. Even NEFA 
AUC in response to glucose and insulin challenges could be measured: in this way it is feasible 
to assess differential responses to treatments (such as dietary energy level or insulin-sensitizing 
agents) in glucose versus lipid metabolism (Shoenberg and Overton, 2010).   
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3.6.3 Surrogate insulin sensitivity indices: HOMA and QUICKI   
In humans surrogate insulin sensitivity indices were developed to test patients with diabetes for 
insulin resistance on a simple and cheap basis. Again after an overnight fast, a single blood 
sample is taken for determination of blood glucose and plasma insulin. In healthy humans, the 
fasting condition represents a basal steady state where glucose is homeostatically maintained 
in the normal range such that insulin levels are not significantly changing and hepatic 
gluconeogenesis is constant. The different indices provide similar but not same results so that 
more than one index should be used when diabetic patients are tested (Muniyappa et al., 
2008). Indices are calculated from plasma concentrations of glucose, insulin, NEFA, or glycerol 
using the following equations:  
1) Homeostasis model assessment (HOMA; Matthews et al. (1985)): 
HOMA = Glucose (mmol/L) x Insulin (µU/mL).  
HOMA-IR uses a fasting sample and is derived from the use of the insulin glucose product, 
divided by a constant: HOMA-IR = {[Glucose (mmol/L) x Insulin (µU/mL)]/22.5} x 0.5 (Radziuk, 
2000; Singh and Saxena, 2010). The denominator of 22.5 is a normalizing factor and derives 
from the product of normal fasting blood glucose (4.5 mmol/L) and insulin (5 μU/mL) in typical 
“healthy humans” (Muniyappa et al., 2008). For using this index in other subjects, basal levels 
of the respective animal have to be considered. The higher HOMA-IR, the higher is IR and the 
lower is insulin sensitivity. Its log-transformation (log (HOMA)) and the reciprocal score 
(1/HOMA) provide better correlations compared to HOMA in evaluation of IR in humans 
(Yokoyama et al., 2003; Muniyappa et al., 2008).  
 
2) Quantitative insulin sensitivity check index (QUICKI; Katz et al. (2000)): 
QUICKI = 1/ [log (Glucose (mg/dL)) + log (Insulin (µU/mL))];  
 
3) Revised quantitative insulin sensitivity check index (RQUICKI; Perseghin et al. (2001)): 
RQUICKI =  1/ [log (Glucose (mg/dL)) + log (Insulin (µU/mL) + log (NEFA (mmol/L))].  
 
4) Modified quantitative insulin sensitivity check index replacing NEFA by glycerol (QUICKI-
glycerol; Rabasa-Lhoret et al. (2003)):  
QUICKI-glycerol = 1/ [log (Glucose (mg/dL)) + log (Insulin (µU/mL) + log (Glycerol (µmol/L))].  
 
5) Revised quantitative insulin sensitivity check index including BHB (Balogh et al., 2008): 
RQUICKI-BHB = 1/ [log (glucose (mg/dl)) + log (insulin (µU/ml)) + log (NEFA (mmol/l)) +log (BHB 
(mmol/l))].   
 
 29 
 
 A low RQUICKI index value indicates decreased insulin sensitivity. 
Recently Holtenius and Holtenius (2007) suggested usage of RQUICKI as an estimate for insulin 
sensitivity also for dairy cattle. However, in ruminants glucose metabolism is significantly 
different from that in monogastrics, blood samples cannot be taken in fasted metabolic states 
and the metabolic state in dairy cows in early lactation (hypo-insulinemia, hypoglycaemia) 
differs substantially from that in diabetic patients (hyper-insulinemia, hyper-glycemia) so that a 
thorough evaluation of accuracy and reliability of surrogate indices appears necessary before 
these tests are widely used. So far, RQUICKI index and GTT results were compared (Balogh et al. 
2008; Kerestes et al. 2009) with controversial findings. Balogh et al. (2008) obtained significant 
correlations between some parameters derived by GTT and the RQUICKI and RQUICKI-BHB, 
whereas Kerestes et al. (2009) did not find any significant correlation between GTT variables 
and the RQUICKI. Nevertheless, such indices appear promising and are already used in research 
studies (Al-Trad et al., 2009;  Bossaert et al., 2009; Stengärde et al., 2010, Schoenberg et al., 
2011) since they are cheap and easy to perform and therefore applicable in large numbers of 
animals. Moreover, pre-sampling fasting procedure is not feasible in ruminants. Energetic 
metabolism during early lactation is essentially different between dairy cows and diabetic 
patients and therefore it substantially influence glucose utilization. For instance, hypoglycaemia 
and hypo-insulinemia are typical of fresh cows after calving, whereas hyperglycaemia and 
hyper-insulinemia are frequent consequences of diabetes. Thus, currently the numeric 
comparison of test results between studies is of limited value and establishment of general 
reference values for surrogate insulin sensitivity indices is difficult.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 30 
 
4. Materials and Methods 
 
4.1 Herds  
This trial involved 3 Holstein-Fresian dairy farms in the province of Padova (Veneto), selected 
for rearing genetically high producing cows and having similar dry cow and transition cow 
management.  One herd (Herd A) was composed of about 270 lactating animals, the second 
herd (Herd B) was composed of 340 lactating animals and the third (Herd C) had 1.100 lactating 
cows. The survey was carried out during spring and summer seasons in 2011. Herd C was 
started first beginning in March and its sampling was ended up in late April; Herd A and B were 
investigated simultaneously beginning in early April and their sampling was ultimated in late 
July. All the three farms were equipped with cooling systems of various kinds for preventing 
heat stress in the summer. The speed of animals’ enrollment in the trial in each herd was 
limited by dry cows availability in those months due to fertility efficiency seasonal variations. All 
farms used to offer a total mixed ration (TMR) ad libitum to both non-lactating and lactating 
cows and TMR was delivered to animals between 9.00 and 11.00 am and refreshed on a daily 
basis, after animals exit from milking parlour in the morning milking session. Cows were milked 
twice a day at 6.00 and 15.00 in the milking parlour. TMR was based on grass hay, alfalfa hay, 
soybean, concentrated feed and silage. Some hay was left in the bunk out of the TMR for non 
lactating cows. Besides, all three farms used to dry-off cows around 60 days before expected 
calving date and adopted a steaming-up phase in late dry period (close-up period) with higher 
energy and protein levels than far-off. The length of close-up period could be variable, ranging 
from 20 to 10 days, according to individual animals and herds, and space availability due to 
animals stocking density. Cows were chosen and moved to the close up pen by the herd 
manager on the basis of their appearance and days left to predicted calving date, given 
estimated gestation length of 275 days. Herd C tended to house cows in the close up pen for 
less days (about 10) according to their nutrition program. Also the energy density and 
composition of far-off and close-up diets could vary between farms but nutritional strategies 
were kept constant during the trial in each herd. Cows were introduced to a new lactation diet, 
with differences in nutrients composition between herds, immediately following parturition. 
Both dry-off and close-up cows were housed in permanent straw bedding pens in all farms, 
whereas immediately after calving they were moved to a new bedding pen for a few days for 
better health check. Fresh cows were monitored once daily by the herd private vet according to 
their routine protocols and treated for diseases. Cows that did not report apparent unhealthy 
state were moved to free stall facilities in larger groups within 10 days in milk. In all farms cows 
were never moved to a maternity unit for calving but calved in the close-up pen. Fresh cows 
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were neither routinely checked for fever nor ketosis in the blood by ketons strips in any herd. 
Fresh cows were checked for clinical signs of diseases, including retained placenta and 
puerperal metritis, and even animals’ appetite, attitude and milk production were taken into 
account by veterinarians for treatment decisions.  
 
Table 1: Composition and contents of the different rations in Herd A 
 
  Herd A 
Item Dry cow Close-up  Fresh cow 
Ingredients (% of DM)       
Corn silage 20,93 - 32,02 
Wheat straw 13,44 11,61 2,06 
Hay 53,52 - 10,68 
Soybean meal 10,65 - 8,96 
Mineral mixture 1,45 2,47 2,22 
Water   -   
Alfalfa hay - 11,52 12,23 
Ground corn silage - - 11,94 
Ground corn - - 10,28 
Cotton seeds - - 4,20 
Sunflower meal  - - 4,16 
Flax seeds - - 1,26 
Fresh cow TMR - 74,40 - 
Chemical analysis, % of DM       
DM (% as fed) 59,28 59,89 53,75 
NEL (Mcal/kg of DM) 1,18 1,39 1,60 
NDF (%) 54,87 40,51 34,18 
NFC (%) 22,58 33,45 40,55 
Starch (%) 7,23 19,60 26,29 
Crude Protein (%) 11,63 14,07 15,20 
Ether extract (%) 1,77 3,44 3,32 
Crude ash (%) 9,06 9,51 6,87 
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Table 2: Composition and contents of the different rations in Herd B 
 
  Herd B 
Item Dry cow Close-up  Fresh cow 
Ingredients (% of DM)       
Corn silage 14,97 30,69 26,34 
Wheat straw 14,89 7,17 - 
Hay 54,14 26,06 - 
Soybean meal 5,90 9,65 - 
Molasses 3,24 1,56 - 
Mineral mixture 1,60 4,42 - 
Water       
Ground corn silage - - 7,48 
Ground corn - 13,76 - 
Sunflower meal  5,27 6,70 - 
Grass silage - - 5,22 
Dry hay and raw material mixture - - 60,95 
Chemical analysis, % of DM       
DM (% as fed) 62,63 51,54 55,42 
NEL (Mcal/kg of DM) 1,22 1,45 1,59 
NDF (%) 54,52 40,49 31,84 
NFC (%) 23,74 34,35 40,92 
Starch (%) 5,02 20,00 26,22 
Crude Protein (%) 12,01 14,20 16,77 
Ether extract (%) 1,89 2,63 3,25 
Crude ash (%) 7,73 6,42 7,33 
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Table 3: Composition and contents of the different rations in Herd C 
 
  Herd C 
Item Dry cow Close-up  Fresh cow 
Ingredients (% of DM)       
Corn silage 35,67 34,56 44,80 
Wheat straw 17,74 17,18 - 
Hay 36,86 35,71 4,34 
Soybean meal 8,78 8,50 8,27 
Mineral mixture 0,96 2,30 2,25 
Water     - 
Alfalfa hay - - 14,49 
Ground corn - - 14,62 
Ryegrass silage - - 4,90 
Flaked soybean - - 6,32 
Flax seeds - 1,75 - 
Chemical analysis, % of DM       
DM (% as fed) 55,76 54,46 54,94 
NEL (Mcal/kg of DM) 1,22 1,26 1,53 
NDF (%) 53,06 51,82 33,39 
NFC (%) 27,89 28,33 42,12 
Starch (%) 13,74 13,39 27,92 
Crude Protein (%) 10,71 11,04 14,07 
Ether extract (%) 2,06 2,62 3,55 
Crude ash (%) 6,23 6,12 6,88 
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4.2 Animals  
Forty-six cows entering second lactation (parity 2) and fifty-five multiparous (parity 3 to 10) 
cows producing mean ± SEM: 10.917 ± 179 kg of fat corrected milk in the previous 305-day 
lactation were randomly selected for the study among animals in the close-up pens of the three 
herds. Cows were within 14 days before expected calving date, considering normal gestation 
length of 275 days and whole physical appearance of calving proximity at the time of selection. 
Cows that were going to calve later than 14 days from the enrollment date were tested again in 
order to obtain all samples from pregnant cows in the range of 14 pre-partum days. These cows 
had a high genetic merit for milk yield. Their milk production in the previous lactation reported 
an average of mean ± SEM 11.480 ± 278 kg of fat corrected milk at 305-day lactation (305EVM) 
for herd A, 10.306 ± 323 for herd B and 11.082 ± 288 for herd C. The final number of cows that 
entered in the trial was 101 and they were evenly partitioned between each farm: 32 animals 
were in herd A, 35 animals in herd B and 34 animals in herd C.  They were apparently in a 
general organic healthy status and were not submitted to any treatment for diseases at least in 
the previous month at the moment of selection.  
 
4.3 The Intravenous Glucose Tolerance Test (IVGTT) 
Glucose tolerance test was performed between days 14-1 before delivery in late gestation 
(Week -1), and after calving, on days 3-9 (Week +1). A single blood sample was collected again 
on days 10-16 of lactation (Week +2) to evaluate further incidence of ketosis in the transition 
period and monitor the evolution of insulin and other metabolites, which might be very 
fluctuant in the first two weeks of lactation. The GTT was not performed at 10-16 days in milk.  
First the animals were selected and restrained by headlocks of the close-up pens up to 30 
minutes before beginning of tests and remained captured during the whole individual test. GTT 
were accomplished serially and thereby some selected cows had to remain locked for a longer 
time.  When a lot of tests were scheduled in a certain day, we managed to postpone the 
capture of some animals. Thus, we let the animals never be restrained longer than one hour 
before GTT. Most tests were performed between 8 and 12 am, sometimes after TMR delivery 
was already completed, and it was not possible to completely control or restrict feed access to 
animals due to obvious requirements of productive cows in a field trial. Some feed was always 
available in mangers, both prior and after daily TMR distribution, even during restraint. 
Simultaneously, an initial blood collection (T0) through a 2.5 ml syringe and 21-gauge x 1 ½” 
needle (0.80 x 40 mm) for basal glucose determination by glucose meter, and a couple of 9 ml-
evacuated tubes containing lithium heparin as anticoagulant (Vacuette®, Greiner Bio-One, 
Kremsmuenster, Austria) were sampled from one jugular vein from each cow. These samples 
were immediately followed by a glucose infusion in the same jugular vein over an average time 
of 5 min. A 14-gauge x 1 ½” needle (2.0 x 40 mm) was inserted in the vein and connected to an 
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urinay defluxor (Haemotronic® S.p.A., Mirandola MO, Italia) for rapid infusion of 300 ml of 
50% glucose solution, approximating a glucose dose of 0.20 to 0.25 g/kg of BW (Glucosio 50 
g/100 mL; solution for infusion, glucose monohydrate, AltaSelect Srl, San Giovanni Lupatoto - 
Verona, Italy). The body weight was estimated based on the average size and condition score of 
the cows in the herd and varied between 600 and 700 kg; great variability in body weights was 
reduced  by excluding heifers from the research. The proper amount of glucose solution was 
prepared before IV administration start. Proper needle insertion in the vein was continuously 
checked during glucose challenge. Whether cows were nervous and therefore IV administration 
was not correctly accomplished, the blood measurements were excluded from the statistical 
analysis. Stress was avoided as much as possible; cows were rigorously blocked against the 
headlocks only during IV infusion. They generally appeared relaxed and were let move their 
head and rest in standing position while waiting for subsequent samples till 80 minutes. 
Moreover, haematological samples were taken before any other manipulations, like daily 
health check, took place to avoid stress because it can modify some hormones and metabolic 
parameters. Also, milking cows were submitted to any pharmacological therapies after the 
completion of the last sample at 80 min since GTT to avoid distorted findings. Therefore, there 
was the chance that a tested cow was treated for diseases last time the previous day, about 24 
h before GTT, or during the morning milking session in case of intra-mammary treatment for 
mastitis. All animals treatments, included hour and date and pharmacological compound 
administered, were registered in our field sheets and weighed up before inclusion of that 
specific GTT in the trial. However, certain interference from herd treatments must be taken into 
consideration and will be discussed in the appropriate chapter. Zero time was set immediately 
after the end of glucose infusion. Additional blood samples, both in Lithium-Eparine tubes and 
syringes for glucometer determination, were obtained on 10 (T10) and 80 min (T80) relative to 
the glucose infusion, on the contro-lateral vein of jugular vein punctured at T0.  
  
                                   Glucose IV 
       cows headlocked                                                                   animals set free 
 
 
 
 
 
 
 
 
≤ 30min    T0           T10                                 T80   
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Blood tubes were stored on ice at less than 4°C in field until centrifuged (10 min at 3.500 x g, 
Labofuge machine) within 1 h of sampling, after the end of field operations, at the Laboratory 
of the Department of Veterinary Clinical Science of the University of Padova. The plasma 
fraction was transferred to a sterile polystyrene tube with a 3-mL plastic pipette. Two aliquots 
of plasma were obtained from each vacutainer and they were stored at −20°C unil analysis. 
After centrifugation, highly and moderately clotted and haemolytic samples were excluded 
from subsequent analysis.  
 
4.4 In field: data collection and analysis 
Data collection  
Data about individual anamnesis were recorded for each cow. We had a work sheet 
predisposed to record the following data: parity, exact dates of sampling relative to calving, 
glucose readings by glucose meter and relative times at sampling on T0, T10 and T80, exact 
time of the end of IV infusion, health records and dates and description of treatments 
submitted to cows. Milk fever, retained placenta, metritis, mastitis, left abomasal displacement 
(LDA) and other specified unhealthy status were checked on the sheet. The health status of the 
cows was estimated subjectively by observation of individual milk yield, attitude and appetite, 
conversation with the herd manager and vet, and regular clinical inspections. Other details like 
dystocia, twins, partum induction were also recorded. Induced calving were less than 5%. Body 
condition score (according to Edmonson procedure (1989) based on 5 points scale) was 
evaluated by the same subject during animal selection in order to estimate the average herd 
body weight of dry cows for administration of adequate volume of IV solution. Milk production 
at 1
st
 APA test and days in milk (DIM) at 1
st
 test, mature cow milk equivalent on 305-d 
(EVM305), calculated as a prevision from 1
st
 milk test in the current lactation, EVM305 in the 
previous lactation, and somatic cells count (SCC) at 1
st
 APA test were later obtained for each 
cow from the APA district of Padova. BHB was also measured twice by a glucose meter post 
partum in order to immediately provide the herd managers with field BHB values that could 
help them in making health evaluation and treatments decision about every single cows. 
 
Below I attach the template sheet for field records of each single cow: 
 
 
 
 
FARM  
COW ID TAG  
COW ID CHAIN  
Lactation N°  
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1. (Week -1) 14 – 1  DAYS PREPARTUM: DATE__________________ 
BCS  
 
 T0 time iv  T10 T80 T80/T0 NOTES 
GLUCOSE       
Time of sample     
 
CALVING DATE: ____________________ 
2. (Week +1) 3 - 9  DAYS POSTPARTUM: DATE_________________ 
BHBA at Time 0  
 
 T0 time iv T10 T80 T80/T0 NOTES 
GLUCOSE       
Time of sample     
 
3. (Week +2) 10 – 16  DAYS POSTPARTUM: DATE ______________ 
GLUCOSE  
BHBA  
 
HEALTH RECORDS 
 YES NO NOTES date 
RIT PLACENTA      
MILK FEVER     
METRITIS     
LDA     
MASTITIS     
OTHER 
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Glucose determination in field: 
After each sample glucose was straight measured in field. We decided to do so in order to 
evaluate the IVGTT as a field test that could be fully realized under field conditions on farms, 
with no need for further laboratory responses. Cow-side glucose measurements were 
conducted on whole blood using a hand-held blood glucose meter (Optium Xceed, ART19558-
004 Rev.A; Abbott Diabetes Care Ltd, Witney, Oxon, UK). Optium Xceed is an instrument 
commonly utilized in human patients for diabetics care. As far as we know, there are no glucose 
meters specifically provided and validated for ruminants. However, Optium Xeed is the most 
diffused meter present in our herds and in other countries because it is extremely accurate and 
user friendly for BHB determination. In fact many herds use to monitor fresh cows for ketosis 
by reading BHB through glucose meter. Optium Xeed is also the most used glocometer in recent 
research in ruminants regarding glucose tolerance loads and heuglicaemic clamp techniques 
(Oetzel, 2010; Schoenberg et al., 2012). For these reasons it was one of the few glucose meters 
considered for comparison with laboratory analysis (McGuirck and Oetzel, 2008; Voyvoda and 
Erdogan, 2010). We used Optium H strips for glucose reading. These strips have been validated 
both for capillary and venous and arterial blood from human subjects. Glucose results were 
displayed in mg/dl in 5 seconds by our instrument and its assay range is 20 – 500 mg/dl. When a 
glucose concentration lower than 20 mg/dl was detected, we reported a glucose value of 20 
mg/dl in our field sheets; similarly, when glucose concentration was indicated as higher than 
500 mg/dl by the glucometer, a value of 500 mg/dl was considered as glucose present in the 
tested sample. The test principle is based on a reaction between glucose and chemicals on the 
test strip, producing a small electrical current proportional to the amount of glucose present in 
the blood. The optimal temperature for glucometer functioning is in the range of 15°-40°C and 
humidity between 10% - 90%. Regarding precision of our instrument, a study in humane 
medicine reported on the Optium H strips user’s instructions shows that results tipically vary by 
no more than 3.0% to 3.6% with high (mean ± SEM 344 ± 10.2 mg/dl) and low (mean ± SEM 51 
± 1.8 mg/dl) glucose concentration respectively. Accuracy of Optium Xceed was measured by 
comparing its results obtained at different medical centers with those obtained using the YSI 
Glucose Analyser: the correlation coefficient in venous blood was 0.99 for glucose range of 70 – 
540 mg/dl.   
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4.5 Laboratory analysis  
One of the series of plasma aliquots have been transfered and stored at -20° at the Laboratory 
of Medical Clinic (Istituto Zooprofilattico Sperimentale delle Venezie, IZSVE) for analysis of 
glucose, basal NEFA and BHB (T0), insulin at T10 and insulin at T80, by use of automated 
equipment and commercial kits based on enzymatic, colorimetric or immunological reactions. 
All samples have been tested for glucose with a Cobas c 501 analyzer (Roche Diagnostics, 
Mannheim, Germany) and Gluc3, glucose HK test (kit no. 04404483190VB, Roche Diagnostics) 
by hexokinase method. The intra-assay coefficient of variation (CV) was < 1% and the inter-
assay CV was < 1.3%. Standardized reference material was tested each day of assay for each 
parameter as a control serum to confirm calibration of the methods. On Cobas C 501 were 
performed also NEFA and β-OHB analysis: basal NEFA concentrations were determined by using 
a colorimetric method, NEFA RX Monza test (kit no. FA 115, Randox, Crumlin, UK) with intra-
assay CV < 4.81% and total-assay CV < 4.51%. Basal samples were analyzed also for BHB 
concentration by RANBUT RX Monza test (kit no. RB 1007, Randox, Crumlin, UK), a UV kinetic 
enzymatic method based on the oxidation of D-3-hydroxybutyrate to acetoacetate by the 
enzyme 3-Hydroxybutyrate dehydrogenase with intra-assay CV < 3,78% and inter-assay CV < 
5,25%. Insulin concentrations at T10 and T80 were measured by using a Immulite One analyzer 
(Siemens, distributed by Medical Systems S.p.A., Genova, Italy) and the commercial INS kit 
(Siemens Healthcare, Diagnostic Products Ltd, Gwynedd, UK), which is a solid-phase, enzyme-
labeled chemiluminescent immunometric assay with intra-assay CV < 6.4% and total-assay CV < 
8%. The minimum detectable level with acceptable precision has been determined as 14.7 
pmol/l. The laboratory of IZSVE provided intra- and inter-assay test results that confirmed the 
CV values stated by the different commercial methods for all the tests used. A value equal to 
14.0 pmol/l of insulin was considered for data analysis in cases of very low insulin 
concentrations not detectable by the immunometric assay.  
At the same time a series of basal plasma aliquots (T0) was analyzed at the Department of 
Veterinary Clinical Science of the University of Padova for determination of Albumin, Globulin, 
Total Proteins, Urea, GOT-AST, GPT-ALT, Calcium, Chlorine, Phosphorus, Magnesium, Potassium 
and Sodium by an automated Biochemistry analyzer BT1500 (Biotecnica Instruments S.p.A., 
Roma, Italy). Plasma concentrations of these parameters were determined by use of Gesan 
reagents (Gesan Production s.r.l., Campobello di Mazara, TP, Italy): Albumin LR for albumin (REF 
C1200620 518 Test, colorimetric bromocresol green BCG method, intra-assay and inter-assay 
CV < 4.15%); Total Protein LR for total proteins (REF E4506100, biuret methods, intra-assay and 
inter-assay CV < 3.92%); Urea UV LR for urea (REF E4800550, Kinetic UV method Urease-GLDH, 
intra-assay and inter-assay CV < 3.70%); AST GOT LR for GOT-AST (REF 3700650, Kinetic UV 
optimized method IFCC, International Federation of Clinical Chemistry and Laboratory 
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Medicine, intra-assay and inter-assay CV < 3.66%); ALT GPT LR for GPT-ALT (REF 3800650, 
Kinetic UV optimized method IFCC, International Federation of Clinical Chemistry and 
Laboratory Medicine, intra-assay and inter-assay CV < 3.71%); Calcium CPC LR for Calcium (REF 
1801030, Colorimetric ocresolphtalein complexone method CPC, intra-assay and inter-assay CV 
< 2.11%); Chloride LR for Chlorine (REF E2100650, Colorimetric method mercurious 
thiocyanate, intra-assay and inter-assay CV < 2.60%); Phosphorus LR for Phosphorus (REF 
C3300620, Colorimetric blue of molybdate method, intra-assay and inter-assay CV < 2.71%); 
Magnesium LR for Magnesium (REF C4400620 518 Test, Colorimetric method Xylidyl Blue, intra-
assay and inter-assay CV < 4.89%); Potassium LR for Potassium (REF 4900430, Turbidimetric 
method, intra-assay and inter-assay CV < 2.75%); Sodium for Sodium (REF 4950180, Kinetic 
enzymatic method, intra-assay and inter-assay CV < 4.72%). Globulins were determined by 
difference between Total Proteins and Albumin concentrations.  
 
Insulin determination at T0 
A series of basal samples (T0) were shipped to the Animal Endocrinology Laboratory, 
Dipartimento di Scienze della Vita e Biotecnologie, University of Ferrara, for quantification of 
insulin by a radio-immunometric-assay in order to be able to calculate the RQUICKI indexes for 
each animal from basal blood collections. Free-insulin concentration in each sample was 
quantified with a commercial 
125
I-IRMA kit developed for human samples (BI-Ins IRMA kit; CIS 
Bio International Ltd.) and previously validated for bovine plasma samples (Kerestes et al., 
2009; 2010). The minimum detectable concentration of free insulin with an acceptable level of 
precision was determined as 1 μUI/ml (7 pmol/l). The higher sensitivity of this method 
compared to a enzyme-labeled chemiluminescent immunometric assay was useful for a better 
determination of very low insulin levels typical of cows approaching calving as was expected in 
T0 samples. The result was reported as 7 pmol/l for statistical analysis whether a non 
detectable insulin level was found by the RIA determination. Samples were assayed in single 
aliquotes. The intra-assay CV was between 3.36 and 4.73%, the inter-assay CV was 4.06%. 
Quality controls were within the 95% confidence limits of the known concentrations. 
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4.6 Data Management and Statistical Analysis 
The goal of this trial was to investigate the responses of animals to FGTT into different herds 
and verify the effect of cows’ ability to respond to the glucose challenge on their energy 
balance and health status. Moreover, we tried the applicability of the test under field 
conditions, by comparison with indicators of insulin resistance and glucose tolerance commonly 
used in human medicine. 
FGTT parameters and animals classification: 
We decided to evaluate T80/T0 glucose ratios above 1.2 as threshold for considering cows that 
had difficulties in returning to basal glucose levels, not responding to glucose load. This 
threshold was already studied in a preliminary trial in late gestation cows by Gianesella and 
colleagues (unpublished data, 2009), and it appeared to be a valid cut-point to distinguish 
animals with altered haematological parameters of glucose and lipid metabolism before 
calving. Therefore the animals were divided in two groups according to their T80/T0 ratios 
measured by glucose meter pre-partum: cows with a T80/T0 lower or equal to 1.2 were 
included in class 0 (FGTT Week-1 class 0), whereas cows with a T80/T0 higher than 1.2 were 
classified as class 1 (FGTT Week-1 class 1).  
Further classifications of animals were used in order to estimate the prevalence of certain 
illnesses after calving in every farm: each cow which experienced any retained placenta, milk 
fever, abomasal displacement, metritis, lameness or culling before 90 DIM was considered 
diseased (Disease class 1), otherwise cows were considered healthy (Disease class 0); either 
cows for which the first milk test highlighted an average SCC higher than 200.000 or cows 
affected by clinical mastitis in the first 30 DIM were classified as diseased (Mastitis class 1), 
compared to normal cows (Mastitis class 0). A percent of the animals treated with any 
pharmacological and anti-ketosic treatment within 10 DIM among cows enrolled in each farm 
was also calculated.  
 
Insulin Resistance indexes calculation: 
Model estimations of insulin resistance were calculated from samples collected at basal times 
(T0) in all weeks (Week -1, Week +1, Week +2) as follows:  
1) revised quantitative insulin sensitivity check index (RQUICKI), as already used by other 
authors in the bovine species (Holtenius and Holtenius, 2007; Kerestes et al., 2009; Bossaert et 
al., 2009; Balogh et al., 2009; Kusenda, 2010) according to this formula:  RQUICKI = 1/[log(G T0) 
+ log(I T0) + log(NEFA T0)], where G T0 = basal laboratory glucose (mg/dL), I T0 = basal insulin 
(μU/mL), and NEFA T0 = basal NEFA (mmol/L).  
2) modified homeostasis model assessment (HOMA-IR), as recently done in dairy cows by other 
researchers (Gellrich, 2012) according to this formula: HOMA-IR = (G T0 x I T0)/22.5, where G T0 
= basal laboratory glucose (mmol/L), and I T0 = basal insulin (μU/mL).  
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Data analysis: 
The data were compared with reference values from local laboratories and checked for outliers 
in excel database; outliers were excluded and all variables were screened for normality by 
calculation of Shapiro Wilk normality test. If necessary, the variables were transformed with the 
natural logarithm to achieve a normal distribution. Gross means were reported in the following 
chapter for specific weeks of sampling and expressed as means ± standard errors of the mean 
(SEM).   
 
A preliminary evaluation was accomplished by checking the Pearson correlations between pre-
partum field T80/T0 ratios and plasmatic NEFA and BHB concentrations both before and after 
calving. A FREQ procedure in SAS (version 9.2, SAS Inst. Inc., Cary, NC) was used to better 
evidence the relative risk of having illnesses and increased plasma NEFA and BHB for cows in 
FGTT Week-1 class 1. Subclinical ketosis was defined as a serum BHBA concentration of ≥ 1.4 
mmol/l (Duffield, 2000). In our trial, cows that resulted in BHB higher than 1.4 mmol/l in Week 
+1 or +2 were grouped in BHB class 1, whereas the others were in BHB class 0. Levels of 
approximately 0.3 mEq/l of pre-partum NEFA and 0.7 mEq/l post-partum have recently been 
identified as critical limit for predicting diseases risk after calving (Ospina et al., 2010). We used 
0.5 mEq/L of NEFA Week -1 and 1.0 mEq/l of NEFA Week +1 as thresholds for classification of 
animals: cows exceeding these values were included in NEFA class 1, otherwise they were in 
NEFA class 0.  
 
An introductory analysis was performed in order to study the hematochemical parameters and 
the IR indexes before calving. For this purpose cows were divided in two pre-partum groups on 
the basis of their enrollment time relative to parturition: cows enrolled on 14 – 7 days before 
calving were distinguished from cows enrolled later than 7 days pre-partum. A multi-way 
analysis of variance (ANOVA) was applied using PROC GLM in SAS to primarily verify any herd or 
week sample effects: qualitative variables included herd, pre-partum week, disease and 
mastitis class, EVM and parity. Cows that had a EVM305 at first milk test < 9.500 kg were 
classified as low productive, a EVM305 of 9.500 – 11.123 kg were classified as fair, and a 
EVM305 > 11.123 kg were high productive animals. Cows were also grouped in two classes 
according to their lactation number by dividing secondiparous animals from older cows. 
Multiple comparisons by Bonferroni method were applied to determine if differences were 
statistically significant (P < 0,05). Particularly interesting results are reported as least square 
means (lsmean) ± pooled standard errors (PSE).  
Secondly, all glucose and insulin measurements and IR indexes in Week -1 were evaluated by a 
multi-way ANOVA to especially test the effect of the FGTT class in Week -1, as defined above, 
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on the hematochemical results pre-partum. The model included herd, EVM, FGTT Week -1, 
mastitis, parity and disease class.  EVM and parity classes were built following the same 
definitions as previously described. A similar statistic was repeated for testing glucose and 
insulin measurements at T10 and T80 in Week +1. Pre-partum and post-partum 
hematochemical results were considered as definitely separate findings. Because basal plasma 
metabolites, insulin and IR indexes were measured twice after parturition, for these baseline 
parameters a repeated-measures approach using ANOVA was used in SAS (PROC MIXED 
REPEATED) including animal effect. Qualitative variables consisted of herd, EVM, FGTT Week -1, 
mastitis, parity, disease and postpartum week classes. The covariance structure was a 
compound symmetry for repeated measurements on cows in postpartum weeks with 2 levels 
of classification (Week +1 and Week +2).  Bonferroni adjustments for estimation of significative 
differences between means (P < 0,05) were applied. The most interesting and significative 
effects due to FGTT and herd classes have been pointed out as lsmean ± PSE.  
 
Afterwards having found an effect of FGTT on IR indexes, we applied the calculation of R.O.C. 
curves (Receiver Operating Characteristic) to evaluate the validity of FGTT performed in Week -
1 in predicting the occurrence of insulin resistance phenomenon in the first couple of weeks of 
lactation. The analysis was carried out by use of MedCalc Software, version 12.3.0 (Broekstraat 
52, 9030 Mariakerke, Belgium). According to the R.O.C. theory, the classification of animals on 
the basis of a cut-off equal to 1.2 for T80/T0 ratios was compared to RQUICKI and HOMA 
determined in post-partum weeks. The Area Under the R.O.C. Curves (AUC), the Z test and the 
Youden Index were calculated both for RQUICKI and HOMA. Furthermore, best cut-off values of 
RQUICKI and HOMA for discerning animals belonging to FGTT class 0 or 1 (Week -1) were 
calculated and respective Sensitivity and Specificity for each index are reported. Final accuracy 
of the IR indexes compared to FGTT was estimated by interpreting their AUC and referring to 
the scheme quoted by Bottarelli and Parodi (2003) and initially proposed by Swets (1998) about 
quality of diagnostic tests.  
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5. Results 
 
5.1 Field data 
First data available in this trial were obtained by field analysis of glucose by glucose meter at all 
sample times (T0 – T10 – T80), followed by individual cow calculation of respective pre-partum 
T80/T0 ratio and classification as “lower than 1.2” (class 0 FGTT) or “higher than 1.2” (class 1 
FGTT) in glucose tolerance test class. Hereafter, the glucose measured by glucometer will be 
reported as Field glucose and by laboratory as Lab glucose; the T80/T0 ratio derived by 
glucometer readings will be reported as Field glucose T80/T0 = FGTT and the ratio derived by 
laboratory analysis as Lab glucose T80/T0 = LGTT. Table 4 and Fig. 1 show the distribution of 
cows enrolled within each farm and their main features, included the frequencies of FGTT 
classes in the three different herds.  
 
Table 4: distribution of total N° of cows tested in the herds, distribution of cows enrolled less 
than 7 days pre-partum and 2
nd
 parity cows in the herds, average DIM, milk production and 
projection of EVM at 305 d at first milk test in each herd. Pooled standard errors (PSE) are 
reported for means. 
Herd A B C 
 Animals 
   
Totals 
N° lactating cows 270 340 1100 
N° tested animals 32 35 34 101 
Frequency (%) 31 34 33 33 
N° tested ≤ 7 d pre-partum 13 25 20 58 
Frequency (%) 41 71 59 57 
N° animals parity 2 14 16 16 46 
Frequency (%) 44 46 47 46 
First milk test mean mean mean PSE 
DIM at 1st test 30,8a 23,5
b
 20,5
b
 2,9 
Milk production at 1st test (kg) 41,2
a
 40
a
 32,8
b
 1,8 
EVM305 1st test (kg) 10761
a
 10740
a
 9480
b
 272 
a, b: means with different superscripts on the same line differ (P < 0,05). 
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Second lactation cows were evenly distributed between farms: herd A had 44% of parity 2 
cows, herd B had 46% of parity 2 cows and herd C had 47% of parity 2 cows. 71% of cows in 
herd B were enrolled in the trial at less than 7 d pre-partum, 59% of cows in herd C and 41% in 
herd A but a significant effect of pre-partum week sub-class was not present on glucose and 
insulin concentrations (see more details following Table 7). Cows in herd A have higher DIM at 
their first milk test because many of them calved in July and were tested in early September 
since August test is normally skipped. However, a mature equivalent with proper adjustments 
for DIM and calving season was determined for better comparison of herds and cows’ 
productions.  
 
Various series of pie chart will be used to display frequencies into different herds: herd A will be 
colored in green, herd B will be colored in blue and herd C in red. 
The percent of cows in class 1 for FGTT in Week -1 was similar within herd A (53%), and herd B 
(54%); it was slightly higher in herd C (59%). The average T80/T0 glucose ratio pre-partum in 
herd A was 1,174 ± 0,035; 1,246 ± 0,046 in herd B and 1,291 ± 0,045 in herd C but a significant 
difference was not found between herds.  
As regard disease incidence (Fig. 2), herd A and C seemed to have comparable percentages of 
illnesses and mastitis cases (disease = 56% for herd A and 62% for herd C; mastitis = 50% for 
herd A and 41% for herd C). Cows in herd B were declared as clinically diseased in fewer cases: 
37% of cows had diseases and 34% had mastitis. Nevertheless, the herd with the higher 
percentage of cows treated with pharmacological and anti-ketotic therapies within 10 DIM 
among tested animals, was herd C (47% versus 19% of herd A and 15% of herd B; Fig. 3).  
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Fig. 1: distribution of cows within FGTT Week -1 class 0 (cows with pre-partum Field T80/T0 ≤ 
1.2) and class 1 (cows with pre-partum Field T80/T0 > 1.2) in each herd: N° of animals and 
respective frequency (%) within the farm are indicated for each class. 
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Fig. 2: distribution of cows within Disease class (charts A, C, E) and Mastitis class (charts B, D, 
F) in each herd: N° of animals and respective frequency (%) in class 0 and 1 within the farm 
are indicated for each class. 
    
    
    
 
 
 
 
A B 
C D 
E F 
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Fig. 3: N° of animals treated with any pharmacological and anti-ketosic treatment within 10 
DIM and respective frequency (%) for each farm. 
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5.2 Hematochemical results: 
Hematochemical parameters determined by laboratories have been reported as gross means 
within specific weeks of sampling relative to calving (Week -1 = 14-1 d pre-partum, Week +1 = 
3-9 d post-partum, Week +2 = 10-16 d post-partum; Table 5). Field glucose average values have 
been included in the same table for completeness as well.  
 
 
General outcomes were in line with expected hematochemical results from normal transition 
cows. Having several post-partum diseased animals in our trial and being interested in studying 
also those ones, a certain deviation of gross means due to pathological situations is acceptable 
and unavoidable. Reported reference ranges are taken from healthy animals and with 68% 
confidence interval, therefore they may apparently look quite restrictive for our sample but the 
presence of unhealthy cattle in our sturdy must be weighed. Glycaemia and insulinaemia 
tended to decrease after calving, with particular low glucose levels in Week +1, concurrently 
with the most frequent cases of hyper-ketonemia and other diseases. In reverse, NEFA and BHB 
concentrations peaked in Week +1, as already found by other authors (Bossaert et al., 2009). 
Calcium concentration was quite stable despite a slight decrease in Week +1 and +2 due to 
physiological hypocalcemia following parturition and onset of lactation in dairy cattle. This 
maintenance of calcemia trough the first days of lactation was confirmed by a very low number 
of milk fever cows registered in our survey (less than 3%) and could have been supported by 
preventive therapies with calcium boli and intravenous administration immediately after 
calving in weak cows, as actually routinely done by all farms. RQUICKI and HOMA indexes were 
rather constant in the first two weeks of lactation; pre-partum RQUICKI average values were 
similar to those determined after calving (0,57 – 0,60) whereas HOMA was slightly higher in the 
pre-partum weeks (0,53) compared to  post-partum (0,41-0,43).  Further, the GOT-AST is easily 
skewed since this parameter tends to become very high in cows suffering from any aspecific 
diseases. Additional reasons for variations and interpretation of this parameter will be better 
discussed in the next chapter.  
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Table 5: Average values of Field and Lab Glucose at different time samples, T80/T0 glucose ratios (Field and Lab T80/T0), Insulin, 
hematochemical parameters, RQUICKI and HOMA with relative standard errors of the mean (SEM) at different sampling intervals.  
reference 
values 23-7d 
prep. (§)
reference 
values < 7d 
prep. (§)
mean SEM
reference 
values < 8d 
postp. (§)
mean SEM
reference 
values 8-25d 
postp. (§)
mean SEM
Field Glucose T0 mg/dl - - 48,36 0,85 - 43,21 1,37 - 44,70 1,05
Field Glucose T10 mg/dl - - 137,53 5,99 - 131,68 5,09 - - -
Field Glucose T80 mg/dl - - 72,40 7,59 - 54,51 3,14 - - -
Field T80/T0 - - - 1,24 0,03 - 1,24 0,04 - - -
Lab Glucose T0 mg/dl 55 - 66 52 - 67 62,68 6,30 53 - 73 51,38 1,61 53 - 69 69,23 19,02
Lab Glucose T10 mg/dl - - 162,74 15,06 - 159,87 19,84 - - -
Lab Glucose T80 mg/dl - - 86,97 13,17 - 62,00 3,53 - - -
Lab T80/T0 - - - 1,19 0,03 - 1,20 0,04 - - -
Insulin T0 pmol/l - - 23,50 1,42 - 20,01 3,76 - 19,13 1,82
Insulin T10 pmol/l - - 351,28 32,60 - 245,60 24,43 - - -
Insulin T80 pmol/l - - 38,76 6,27 - 28,14 5,61 - - -
BHB mmol/l 0,25 - 0,42 0,33 - 0,51 0,53 0,04 0,35 - 0,62 1,21 0,11 0,32 - 0,60 1,04 0,10
NEFA meq/l 0,08 - 0,36 0,00 - 0,54 0,42 0,03 0,58 - 1,00 0,80 0,04 0,35 - 0,88 0,66 0,03
Albumin g/l 36 - 41 34 - 41 34,65 0,34 34,0 - 42,7 33,44 0,37 34 - 43 32,58 0,37
Globulin g/l 34 - 43 27 - 39 43,07 0,69 34 - 43 46,21 0,70 38 - 48 48,52 0,67
Total Proteins g/l 72 - 82 64 - 76 77,73 0,74 71 - 83 79,66 0,82 75 - 90 81,11 0,74
GOT - AST u/l 45 - 72 50 -69 80,79 2,36 68 - 100 147,62 7,42 64 - 90 136,48 7,23
GPT - ALT u/l 11 - 23 12 - 22 11,42 0,69 13 - 23 12,05 0,48 15 - 25 12,34 0,63
Urea mg/dl 15,7 - 25,6 17,7 - 27,0 30,74 0,95 19,2 - 32,4 30,52 1,56 19,4 - 32,2 28,23 1,36
Calcium mg/dl 8,92 - 9,60 8,64 - 9,64 9,84 0,08 7,96 - 9,36 9,63 0,09 8,6 - 9,52 9,65 0,08
Chlorine mmol/l 103 - 108 105 - 110 105,19 0,34 100 - 107 101,84 0,31 99 - 104 100,70 0,31
Phosphorus mg/dl 5,76 - 7,50 4,90 - 6,90 6,64 0,15 4,19 - 6,12 6,07 0,15 4,59 - 6,67 5,90 0,16
Magnesium mg/dl 1,99 - 2,50 1,94 - 2,43 2,46 0,05 0,79 - 1,06 2,21 0,04 2,18 - 2,77 2,41 0,05
Potassium mmol/l 3,93 - 4,58 3,86 - 4,71 3,73 0,05 3,70 - 4,44 3,43 0,06 3,66 - 4,34 3,29 0,06
Sodium mmol/l 140 - 145 143 - 148 142,92 0,30 137 - 145 141,87 0,32 136 - 142 140,72 0,41
RQUICKI - - - 0,60 0,01 - 0,58 0,01 - 0,57 0,01
HOMA - - - 0,53 0,07 - 0,41 0,09 - 0,43 0,07
Parameter Unit
week -1 week +1 week +2
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§) Reference values for multiparous healthy cows from Istituto Zooprofilattico Sperimentale della 
Lombardia ed Emilia Romagna “Bruno Ubertini” (IZSLER), within 68% confidence intervals and specific 
periods (23-7 days pre-partum; < 7 days pre-partum; < 8 days post-partum; 8-25 days post-partum).  
 
 
 
 
Fig. 4: distribution of cows in NEFA class in Week-1 (charts A, C, E) and NEFA class in Week +1 
(charts B, D, F) in each herd: N° of animals and respective frequency (%) in class 0 and 1 
within the farm are indicated for each class. 
        
    
     
A B 
C D 
E F 
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Fig. 5: distribution of cows in BHB class in Week+1 and/or +2 in each herd: N° of animals and 
respective frequency (%) in class 0 and 1 within the farm are indicated for each class. 
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Fig. 6: Correlation between Field Glucose T80/T0 ratios (FGTT) and NEFA in Week-1.  
 
A simple correlation between the FGTT ratios and NEFA was determined. A significant 
relationship was observed in Week -1 as shown in Fig. 6 (R = 0,4; P < 0,0001). Neither a 
significant correlation between the FGTT pre-partum and the FGTT post-partum was found, nor 
between the FGTT in Week -1 and NEFA or ketonemia in Week +1/+2. The FGTT in Week +1 was 
further compared to NEFA and BHB in the same post-partum week with no interesting results. If 
considering laboratories glucose measurements, the correlation coefficient R between LGTT 
and NEFA in Week -1 was 0,28 (P < 0,0001). General correlation coefficient R between LGTT and 
FGTT was 0,5 independently of week sample (P < 0,0001).  
The Relative Risk (RR) of cows in FGTT class 1 pre-partum to be classified as NEFA class 1 cows 
pre-partum (class 1 = NEFA > 0,5 meq/l) was 2,18 (95% CI = 1,00 – 4,75; P < 0,05). Other risks of 
developing hyper-ketonemia, diseases and mastitis after calving for cows with high pre-partum 
NEFA were verified but no significance was observed. Only cows with NEFA higher than 1 meq/l 
in Week +1 had a significant risk of having high BHB in the same week sample (RR = 6,9; 95% CI 
= 2,70 – 17,35; P < 0,001). 
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Table 6: Relative Risk (RR) of cows in NEFA or FGTT class 1 pre-partum (“Risk cases”) to be 
classified as Disease, Mastitis, BHB or NEFA class 1 cows post-partum (“Diseased cases”). All 
tested cases with respective significance levels (P) and confidence intervals (CI) are reported. 
In addition, the RR of cows in NEFA class 1 in Week+1 to be in BHB class 1 after calving was 
verified. The RR of cows in FGTT class 1 in Week-1 to be in NEFA class 1 before calving was 
also considered. NS = Not Significant (P < 0,05). 
Risk  cases Diseased cases P RR CI 
NEFA week-1 Disease NS 1,35 0,93 - 1,97 
NEFA week-1 Mastitis NS 1,22 0,74 - 1,99 
NEFA week-1 BHB week+1 and +2 NS 1,77 0,98 - 3,18 
NEFA week+1 BHB week+1 < 0,001 6,9 2,70 - 17,35 
FGTT week-1 Disease NS 1,32 0,88 - 1,96 
FGTT week-1 BHB week+1 and +2 NS 0,73 0,41 - 1,30 
FGTT week-1 BHB week+1 NS 0,64 0,28 - 1,45 
FGTT week-1 NEFA week-1 0,037 2,18 1,00 - 4,75 
FGTT week-1 NEFA week+1 NS 1,02 0,54 - 1,89 
 
A preliminary analysis of Week -1 hematochemical parameters revealed a similar pattern for 
insulin and NEFA in herds B and C, with average higher NEFA and lower insulin compared to 
herd A, as shown in Fig.1. Lower Urea, GOT-AST and GPT-ALT were also found both in herd B 
and C compared to herd A (P<0,001). Albumin and Total proteins were lower in herd C 
compared to herds A and B (P<0,001) (Table 7 and Fig. 7, 8, 9).  
Only means for herd class have been shown in the table because, as initially mentioned, other 
significant effects of pre-partum week, parity, evm and diseases classes were not evident. 
Nevertheless, glycaemia at T80 in Week -1 was higher in cows enrolled less than 7 d pre-partum 
(least squared means are 59,45 ± 14,14 in cows enrolled 14-7 d pre-partum and 90,04 ± 12,47 
in cows enrolled ≤ 7 d pre-partum; P = 0,1065). Otherwise, glycaemia at T0 in the two pre-
partum weeks sub-classes was rather similar (least square means are 48,33 ± 1,49 at 14-7 d pre-
partum and 49,06 ± 1,32 ≤ 7 d pre-partum, P = 0,7161). Also, cows enrolled ≤ 7 d pre-partum 
showed lower insulin at T0 (22,33 ± 1,89 compared to 25,62 ± 2,17 at 14-7 d pre-partum, P = 
0,2635) and T10 (307,68 ± 50,02 compared to 453,62 ± 56,72 at 14-7 d pre-partum, P = 0,0557). 
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Significantly higher plasma NEFA appeared in the same cows (least squared means are 0,49 ± 
0,04 compared to 0,34 ± 0,05 at 14-7 d pre-partum, P = 0,0289).  
Table 7: Least squared means (lsmean) and pooled standard errors (PSE) for basal pre-partum 
Field Glucose, Insulin and hematochemical parameters in different Herds, and statistical 
significance observed. Only significantly different lsmeans have been reported (P < 0,05). 
ab, means with different superscripts on the same line differ with P < 0,05; cd P < 0,01; ef P < 0,001. 
 
 
 
 
 
 
 
 
 
 
Parameters Unit FValue P 
Herd 
PSE 
A B C 
Field Glucose 
T0 
mg/dl 3,61 0,032 50,10 44,98
b
 51,02
a
 1,73 
Insulin T0 pmol/l 5,47 0,006 30,87
e
 17,69
f
 19,68
f
 2,56 
NEFA meq/l 7,35 0,001 0,25
f
 0,55
e
 0,47
e
 0,06 
Albumin g/l 14,82 < 0,0001 34,76
e
 36,66
e
 32,31
f
 0,56 
Total proteins g/l 6,48 0,003 80,14
c
 80,25
c
 73,68
d
 1,45 
GOT-AST u/l 8,91 0,0003 89,48
e
 71,81
f
 70,18
f
 3,42 
GPT-ALT u/l 11,62 < 0,0001 16,34
e
 9,56
f
 9,69
f
 1,14 
Urea mg/dl 17,27 < 0,0001 38,68
e
 27,66
f
 26,54
f
 1,61 
Chlorine 
mmol/
l 
12,69 < 0,0001 105,85
e
 107,15
e
 102,95
f
 0,60 
Sodium 
mmol/
l 
12,53 < 0,0001 144,29
e
 143,33
e
 140,48
f
 0,54 
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Fig. 7: Least squared means for basal Field Glucose, Insulin and NEFA in Week-1 in Herd class. 
Means with different letters between herds differ as indicated by superscripts in table 7.   
 
Fig. 7: Least squared means for basal Albumin, Urea and Total Proteins in Week-1 in Herd 
class. Means with different letters between herds differ as indicated by superscripts in table 
7.   
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Fig. 8: Least squared means for basal GOT-AST and GPT-ALT in Week-1 in Herd class. Means 
with different letters between herds differ as indicated by superscripts in table 7.   
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Table 8: Statistical significances observed for pre-partum Field and Lab Glucose determinations and Insulin at different time 
samples, for RQUICKI and HOMA, and for post-partum Field and Lab Glucose and Insulin at T10 and T80, within Herd, EVM, FGTT 
Week-1, Mastitis, Parity and Disease Classes. NS = Not Significant (P < 0,05). 
FValue P FValue P FValue P FValue P FValue P FValue P
Field Glucose T0 3,082 NS 0,066 NS 5,719 0,019 0,766 NS 0,384 NS 0,444 NS
Field Glucose T10 1,419 NS 0,216 NS 1,018 NS 1,296 NS 3,300 NS 0,585 NS
Field Glucose T80 4,987 0,009 0,115 NS 31,468 < 0,0001 1,572 NS 3,378 NS 0,669 NS
Lab Glucose T0 0,188 NS 0,311 NS 0,228 NS 0,586 NS 1,480 NS 0,025 NS
Lab Glucose T10 0,591 NS 1,007 NS 0,302 NS 1,068 NS 0,706 NS 0,007 NS
Lab Glucose T80 0,0067 NS 0,328 NS 1,723 NS 0,841 NS 0,437 NS 0,915 NS
Insulin T0 7,105 0,001 2,915 NS 0,101 NS 0,017 NS 0,191 NS 0,012 NS
Insulin T10 0,89 NS 0,327 NS 9,007 0,004 0,000 NS 0,011 NS 0,000 NS
Insulin T80 0,255 NS 1,262 NS 0,003 NS 0,840 NS 0,663 NS 0,002 NS
RQUICKI 2,743 NS 0,848 NS 1,113 NS 0,041 NS 1,961 NS 0,249 NS
HOMA 5,82 0,004 1,595 NS 0,059 NS 0,082 NS 0,151 NS 0,313 NS
Field Glucose T10 1,507 NS 0,848 NS 0,034 NS 3,125 NS 0,424 NS 0,024 NS
Field Glucose T80 0,009 NS 0,228 NS 0,001 NS 0,049 NS 0,072 NS 0,819 NS
Lab Glucose T10 0,368 NS 0,855 NS 0,011 NS 0,978 NS 0,416 NS 0,777 NS
Lab Glucose T80 0,816 NS 0,428 NS 0,07 NS 0,007 NS 0,003 NS 0,298 NS
Insulin T10 0,173 NS 2,905 NS 0,028 NS 0,66 NS 2,326 NS 0,269 NS
Insulin T80 1,702 NS 4,266 0,018 0,839 NS 0,029 NS 0,981 NS 0,001 NS
W
e
e
k
+
1
W
e
e
k
-
1
Parameter
Herd Class EVM Class FGTT Week-1 Class Mastitis Class Parity Class Disease Class
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Table 9: Statistical significances observed and cow effect (%) over post-calving repeated T0 Field and Lab Glucose determinations, 
Insulin, hematochemical parameters, RQUICKI and HOMA within Herd, EVM, FGTT Week-1, Mastitis, Parity, Disease and 
Postpartum week Classes. NS = Not Significant (P < 0,05).  
FValue P FValue P FValue P FValue P FValue P FValue P FValue P
Field Glucose T0 3,237 0,045 3,933 0,024 1,333 NS 0,049 NS 0,334 NS 0,000 NS 0,143 NS 22
Lab Glucose T0 5,829 0,004 4,926 0,010 3,289 NS 0,018 NS 4,538 NS 0,020 NS 0,446 NS 17
Insul in T0 0,860 NS 1,382 NS 2,933 NS 2,054 NS 0,425 NS 0,836 NS 0,003 NS 3
BHB 1,765 NS 0,600 NS 0,873 NS 0,323 NS 4,747 0,032 1,216 NS 5,986 0,017 44
NEFA 2,259 NS 0,737 NS 0,497 NS 0,017 NS 8,178 0,005 0,000 NS 12,295 0,0007 37
Albumin 25,324 <0,0001 2,105 NS 5,368 0,023 0,153 NS 0,497 NS 2,086 NS 8,101 0,006 22
Globulin 1,261 NS 10,007 0,0001 0,217 NS 2,221 NS 2,099 NS 1,449 NS 13,904 0,0003 44
Total Proteins 9,357 0,0002 5,531 0,006 0,330 NS 1,517 NS 2,796 NS 0,251 NS 1,896 NS 14
GOT - AST 0,114 NS 1,214 NS 0,003 NS 0,000 NS 0,036 NS 1,066 NS 1,406 NS 49
GPT - ALT 4,478 0,015 1,177 NS 0,485 NS 3,208 NS 0,789 NS 1,354 NS 0,433 NS 42
Urea 0,443 NS 0,995 NS 0,276 NS 2,677 NS 1,228 NS 1,225 NS 4,668 0,034 57
Calcium 8,641 0,0004 1,804 NS 2,372 NS 0,084 NS 0,342 NS 0,496 NS 0,018 NS 13
Chlorine 9,423 0,0002 0,144 NS 1,419 NS 1,059 NS 0,045 NS 6,367 0,014 6,181 0,015 <0.01
Phosphorus 14,213 <0,0001 1,458 NS 0,024 NS 1,910 NS 2,489 NS 1,527 NS 2,394 NS 31
Magnesium 6,593 0,002 0,458 NS 0,591 NS 0,427 NS 0,304 NS 0,682 NS 8,945 0,004 35
Potassium 1,620 NS 0,762 NS 0,364 NS 0,027 NS 0,000 NS 1,532 NS 4,615 0,035 36
Sodium 2,229 NS 1,653 NS 0,401 NS 2,346 NS 0,528 NS 1,979 NS 5,195 0,025 22
RQUICKI 6,116 0,003 1,318 NS 6,280 0,014 0,363 NS 0,969 NS 0,006 NS 1,620 NS 20
HOMA 1,421 NS 2,358 NS 6,465 0,013 2,557 NS 0,134 NS 1,669 NS 0,038 NS <0.01
Disease Class
Postpartum week 
Class
Cow       
effect     
(%)
Parameter
Herd Class EVM Class FGTT Week-1 Class Mastitis Class Parity Class
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A summary of the statistics performed by inclusion of the FGTT class was proposed in table 8 
and 9 above. The most physiologically interesting and significant effects due to FGTT and herd 
classes have been pointed out in table 10. Differences in T80/T0 ratios between class 0 and 1 of 
FGTT Week-1 were given by both lower T0 and higher T80 glucose concentrations (Fig. 9). In the 
pre-partum weeks a deficiency in FGTT response was accompanied by lowered levels of plasma 
insulin at T10 (class 0 FGTT = 350,72, class 1 FGTT = 180,73), whereas the same difference was 
not noted at T10 in Week +1 (class 0 FGTT = 261,07 ± 38,57, class 1 FGTT = 270,27 ± 36,37; P > 
0,05) (Fig. 12). Cows with pre-partum T80/T0 ratios > 1.2 interestingly had higher RQUICKI and 
lower HOMA indexes for the first couple of weeks after calving as displayed in Fig. 15. Herds 
effects over FGTT parameters and IR indexes were confirmed both pre and post-partum. Herd B 
and C could be qualified as more “insulin resistant” if compared to herd A on the basis of their 
post-partum RQUICKI indexes (Fig. 13). In particular, herd C also showed higher glucose 
concentrations at T0 in Week +1 against the other two farms. On the contrary the same herds B 
and C exhibited a higher insulin sensitivity pre-partum according to their HOMA indexes (Fig 
11), which were lower than herd A, and were both characterized by lower basal insulin levels. A 
comment about this point will be given in the discussion.  
Table 10: Least squared means (lsmean) and pooled standard errors (PSE) of Field Glucose, 
Insulin, Albumin, HOMA and RQUICKI for most physiologically interesting pre and post-
partum effects due to FGTT Week-1 class and Herd class, and statistical significance observed. 
Only significantly different lsmeans have been reported; NS = Not Significant (P < 0,05). FGTT 
class 0 = cows with field T80/T0 ≤ 1.2; FGTT class 1 = cows with field T80/T0 > 1.2. 
Parameter Unit 
FGTT Week-1 Class Herd 
PSE 
0 1 A B C 
W
e
e
k
 -
1
 
Field Glucose T0 mg/dl 51,32
c
 46,70
d
 NS NS NS 1,32 
Field Glucose T80 mg/dl 52,30
f
 64,78
e
 57,05 54,75
d
 63,24
c
 1,73 
Insulin T0 pmol/l NS NS 31,76
e
 21,16
f
 19,14
f
 2,45 
Insulin T10 pmol/l 350,72
c
  180,73
d
 NS NS NS 40,53 
HOMA - NS NS 0,53
c
 0,31
d
 0,30
d
 0,04 
W
e
e
k
 +
1
/+
2
 Field Glucose T0 mg/dl NS NS 42,40
b
 43,60
b
 48,40
a
 1,77 
Albumin g/l 32,20
b
 33,40
a
 33,90
e
 34,40
e
 30,20
f
 0,43 
RQUICKI - 0,59
a
 0,55
b
 0,61
c
 0,54
d
 0,55
d
 0,02 
HOMA - 0,29
d
 0,62
c
 NS NS NS 0,10 
ab, means with different superscripts on the same line, within FGTT or Herd class, differ with P < 0,05; cd 
P < 0,01; ef P < 0,001. 
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Fig. 9: Least squared means for Field Glucose at T0 and T80 in Week-1 within FGTT Week-1 
class. Means with different letters between class 0 and class 1 differ as indicated by 
superscripts in table 10.   
 
 
Fig. 10: Least squared means for Insulin at T0 in Week-1 within Herd class. Different letters 
between herds indicate a significant difference as indicated by superscripts in table 10.   
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Fig. 11: Least squared means for HOMA in Week-1 within Herd class. Different letters 
between herds indicate a significant difference as indicated by superscripts in table 10.   
 
 
Fig. 12: Least squared means for Insulin at T10 in Week-1and Week+1 within FGTT Week-1 
class. Means with different letters between class 0 and class 1 differ as indicated by 
superscripts in table 10.   
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Fig. 13: Least squared means for post-partum RQUICKI and Field Glucose at T0 in different 
herds. Means with different letters between herds differ as indicated by superscripts in table 
10.   
 
 
Fig. 14: Least squared means for post-partum Albumin concentration at T0 in different herds. 
Means with different letters between herds differ as indicated by superscripts in table 10.   
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Fig. 15: Least squared means for post-partum RQUICKI and HOMA within FGTT Week-1 class. 
Means with different letters between class 0 and class 1 differ as indicated by superscripts in 
table 10.  
 
 
 
In order to assess the accuracy of our FGTT and the applicability of RQUICKI and HOMA as 
marker of insulin sensitivity in dairy cattle, we applied the calculation of R.O.C. curves by 
comparing tests between each others and using FGTT classes (0 and 1), performed in Week -1, 
as classification variable. We interpreted the values of area under the curves (AUC)  following 
Bottarelli’s schema: both RQUICKI and HOMA produced an AUC of about 0,6 which would 
classifie the tests as poorly accurate. The value of Z is similar and higher than a critic value of 
1.96 for both indexes, which means that these indexes are significantly different between class 
0 and 1 of FGTT. The Z of RQUICKI is slightly higher than HOMA so it is possible to state that its 
performance is superior in discriminating cows above or below the T80/T0 ratio of 1.2 (with P < 
0,05). The associated criterion gives the cut-off values of tests for identifing “insulin resistant” 
cows: if RQUICKI is ≤ 0,558, than the respective T80/T0 is > 1.2 (P < 0,01); again if HOMA is > 
0,246, than the T80/T0 is > 1.2 (P < 0,05).  
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Table 11. Area Under the R.O.C. Curves (AUC), Z test, and cut-off values (Association criterion) 
for determination of best Sensitivity and Specificity as diagnostic test of RQUICKI and HOMA 
used post calving (Week +1 and +2) as indexes of IR and compared to FGTT performed in 
Week-1 as classification variable. All statistics are followed by respective levels of significance 
(Standard Errors, SE; 95% Confidence Interval, 95% CI; P values, P). 
Tested variables                                      
RQUICKI 
Week+1/+2 
HOMA  
Week +1/+2 
AUC 0,619 0,602 
SE 0,0413 0,0415 
95% CI 0,545 - 0,689 0,528 - 0,673 
Z statistic 2,873 2,459 
P 0,0041 0,0139 
Associated criterion ≤ 0,558 > 0,246 
95% CI 0,476 - 0,582 0,124 - 0,326 
Sensitivity (%) 63,00 55,00 
95% CI 52,8 - 72,4 44,7 - 65,0 
Specificity (%) 65,12 67,44 
95% CI 54,1 - 75,1 56,5 - 77,2 
 
Graphically looking at the curves, a test A is considered better than a test B when its curve is 
completely above the curve of the second one. Sensitivity and Specificity of tests compared to a 
reference variable are graphically showed by the curve trend. In this case, post-partum RQUICKI 
and HOMA curves are almost identical: sensitivity is 63% and 55% for RQUICKI and HOMA, 
respectively; specificity is inverted and slightly higher for HOMA (67%) than for RQUICKI (65%).  
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Fig. 16:  R.O.C. curve of RQUICKI calculated during Week +1 and +2 and tested as an indicator 
of insulin resistance in dairy cows in association with FGTT performed in Week -1.  
 
Fig. 17:  R.O.C. curve of HOMA calculated during Week +1 and +2 and tested as an indicator of 
insulin resistance in dairy cows in association with FGTT performed in Week -1.  
 
 
RQUICKI 
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For concluding results,  cows with lower milk production had higher basal glycaemia (EVM class 
1 = 50,04 ± 2,32; class 2 = 43,07 ± 1,39; class 3 = 41,30 ± 2,06) as presented in Fig. 18. 
Moreover, older animals suffered from post-calving more severe negative energy balance 
(NEFA in parity 2 class = 0,64 ± 0,05; NEFA in parity 3 class = 0,82 ± 0,04; P < 0,01) and ketosis 
(BHB in parity 2 class = 0,75 ± 0,08; BHB in parity 3 class = 0,99 ±0,08; P < 0,05) (Fig. 19).  
Fig. 18: Least squared means for post-partum Field Glucose concentrations at T0 within EVM 
class. EVM class 1: EVM305 < 9.500 kg; class 2: 9.500 kg ≤ EVM305 ≤ 11.123 kg; class 3: 
EVM305 > 11.123 kg. Means with different letters between classes differ (P = 0,01 – 0,05).  
 
 
Fig. 19: Least squared means for post-partum BHB and NEFA concentrations within Parity 
class. Parity class 2: cows at their second lactation; parity class 3: cows ≥ 3 lactations. Means 
with different letters between class 2 and 3 differ (ab, P < 0,05; cd, P = 0,001 – 0,01 ).  
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6. Discussion 
 
6.1 The FGTT 
The central aim of this study was to assess the insulin response to a glucose load at different 
time points relative to calving in cows with different glucose clearance capacity and health 
status. Patterns of plasma glucose and insulin responses to GTT in this trial were comparable to 
those obtained elsewhere: our decision to measure glucose at T80 was derived by the 
expectation that it should be returned to basal levels within 80 minutes from the end of 
infusion under physiological conditions, in line with other authors findings during GTT carried 
out in the transition cow (Roche et al., 2008; Terao et al., 2010; Grunberg et al., 2011). Samples 
were also collected 10 minutes later with particular interest for insulin determination because 
T10 could likely be the moment of insulin serum peak concentration as it was found in 
prepartum GTT (Hayirli, 2001) and postpartum GTT (Balogh et al., 2009) characterized by similar 
glucose dosage administration (0.15 g/kg of BW). We verified these assumptions by performing 
our GTT as described above in a small number of cows and measuring both glucose and insulin 
concentrations at close intervals over time (every 10 minutes over 2 hours), before the 
beginning of our survey. In our results, a fair concordance (R = 0,5) was found between glucose 
ratios measured by Optium Exceed and laboratory methods, as previously affirmed by other 
authors: both Oetzel and McGuirk (2008) reported a correlation with R2 = 0,56, and Voyvoda 
and Erdogan (2010) showed a correlation coefficient (r) of 0,63 between the same hand-held 
device and laboratory analysis from basal samples of clinically healthy Holstein cows. A notable 
reduction in insulin release was pointed out at T10 within Week -1 in cows with pre-partum 
T80/T0 ratios > 1.2: this outcome suggests that glucose uptake by peripheral tissues in late 
gestation cows could be compromised not only by peripheral insulin resistance but also by an 
excessive reduction in insulin secretion and pancreatic synthesis in specific subjects. The degree 
of insulin production and insulin action are known to be affected by various hormones, as GH, 
cortisol, progesterone and thyroxine (Hayirli, 2006; Stern et al., 1971) and free fatty acids 
(Bassett & Gluckman 1987). All these hormones and metabolites normally undergo important 
modifications in late pregnancy. Plasma NEFA concentration increases because fat is mobilized 
in response to decreased plasma insulin concentration, which starts declining beginning several 
weeks pre-partum. Insulin and NEFA exert a reciprocal negative effect even if the exact 
molecular mechanisms are not extensively explained yet. In humans, prolonged periods of 
elevated NEFA concentrations, such as obesity, increase the risk of type II diabetes mellitus. 
This seems to be due to exhaustion of the Langerhans islets after prolonged episodes of insulin 
 69 
 
resistance and hyper-insulinaemia (Golay and Ybarra, 2005). Apart from this, a direct 
deleterious effect of fatty acids on the pancreatic β-cell insulin secretion and viability has been 
demonstrated by in vitro studies in man (Zhou and Grill, 1995) and rat (Maedler et al., 2001). 
Because dairy cows are also exposed to high-NEFA concentrations throughout periods of NEB, it 
could be hypothesized that they also suffer from an impaired insulin secretion.  
Higher NEFA were seen in cows enrolled in our trial at less than 7 d before calving. Indeed, free 
fatty acids usually increase remarkably approaching calving and they reach peak concentration 
within the first week of lactation (Bossaert et al., 2008). Simultaneously, these animals had 
lower insulin detectable before glucose infusion and 10 minutes later and their glycaemia at 
T80 was slightly higher as opposed to cows involved in the trial between 14 and 7 d pre-partum. 
A possible interference of NEFA and peri-parturient endocrinal changes with insulin secretion 
and glucose clearance can be assumed. Herd B and C were characterized by an elevated 
number of animals selected in the week period closest to delivery and were also suffering from 
higher NEFA and lower insulin concentrations. Other basal biochemical parameters as urea, 
albumin, total proteins, GOT-AST and GPT-ALT in Week -1 in these herds suggest a risk of lower 
dry matter intake (DMI) on the whole. In general DMI is gradually decreasing in the few weeks 
before parturition. Therefore, the exact time of performance of glucose challenge in terms of 
days relative to calving must be considered before any in-depth analysis of other factors 
responsible for IR problems on farms. Otherwise, the observation of a strong herd effect over 
glucose, insulin, energetic metabolites and IR indexes is indicative of a potential responsibility 
of nutritional and managerial elements in causing metabolic disorders and compromised 
glucose tolerance. Looking at diets composition, herd C can be theoretically differentiated by 
the other two herds in particular for its reduced NEL, starch and crude protein percents in 
close-up stage. Indeed, these elements would predispose to IR syndrome in transition cows 
according to many researchers. Besides this, DMI could play a crucial role: social stressors as 
bunk space availability and overcrowding could further affect DMI despite similar diets 
composition. However, we did not measure DMI and the extension of close-up periods for 
single cows: investigating IR causes was not our purpose. To elucidate the causal factors of this 
phenomenon, further experimental studies are required with particular attention to energy and 
protein density of close-up diets and length of close-up stage. Furthermore, hepatic and body 
fat content and their effects on liver processes and fat storage seem to be highly variable 
among cows. This indicates that individual cow factors beyond environment and feeding 
management affect energetic metabolism and consequently performance of high-yielding dairy 
cows (McNamara, 2000; Ingvartsen, 2006; Hammon et al., 2009) and should be better 
investigated. In addition, usually plasma glucose concentration drops precipitously at calving 
and partially recovers over the course of the next several weeks. Low plasma glucose likely 
limits milk yield because glucose is required by the mammary gland for the production of milk 
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lactose, the primary determinant of milk volume. Unexpectedly, we observed higher glucose 
levels in cows with limited milk yield at first milk test as already seen by Balogh et al. (2008): a 
rapid insulin-independent uptake of glucose by mammary gland following intravenous infusion 
could be supposed in higher producers, with concurrent reduced glycaemia. The herds, B and C, 
with the higher glycaemia in Week +1 and +2, had also lower insulineamia and productivity. 
Thus, the level of glycaemia could also be a direct consequence of actual impairment of insulin 
release. Reduced feed consumption may be related to insulin availability and contribute to 
limited milk yield in herds with lowered insulinemia and apparently elevated glucose 
concentrations.  
In humane medicine, a form of Gestational diabetes mellitus (GDM) exists as a “slight and 
temporary glucose intolerance that occurs or is recognized during pregnancy for the first time 
and usually ceases after calving” (American Diabetes Association, Diabetes Care, Volume 27, 
Supplement 1, 2004). The GDM is the result of an altered adjustment of metabolism to insulin 
resistance produced by hormonal changes during gestation (Catalano et al., 1991). Pregnant 
women with no GDM reply to a reduced peripheral tissue sensitivity to insulin by increasing 
insulin release. In the subjects who cannot raise insulin secretion, hyper-glycaemia appears and 
stimulates the fetal pancreas with consequent increase of fetus growth and other metabolic 
disturbances (Phillipps and Jeffries, 2006). In the post-partum the decline of peripheral insulin 
resistance reduces the insulin demand and therefore its secretion, so that β-cells activity is 
sufficient regardless of persistency of a certain degree of deficit in insulin production. Anyway, 
controversial findings have been reported on the levels of insulin secretion in GDM patients. 
Peripheral insulin concentrations likely do not adequately reflect insulin secretion. A high 
percent of secreted insulin is metabolized by the liver at a different rate between GDM and 
non-GDM women (Xiang et al., 1999). Moreover, in the past many analytical assays cross-
reacted with insulin precursors, which could be elevated in GDM patients (Kautzky-Willer et al., 
1997). Nowadays, the best method for assessment of pre-hepatic insulin secretion is 
considered the detection of C peptide concentration in the venous peripheral blood and thus its 
use in the bovine species could be evaluated. Similarly, the development path of GDM 
syndrome in humans may be comparable to the dynamics of insulin resistance complex in dairy 
cows during pregnancy and after calving.  
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6.2 The Negative Energy Balance 
In our study we also aimed at relating cows’ response to glucose load to their metabolic status. 
For evaluation of possible associations between responses to GTT and ketosis syndrome, we 
considered BHB and NEFA concentrations. Serum concentrations of the ketone body BHB are 
commonly used to diagnose ketosis in dairy cows. By use of a case definition of serum BHBA 
concentration > 1.4 mmol/l, Geishauser and colleagues (2000) estimated an incidence rate of 
12% for subclinical ketosis among postpartum cows in their first lactation; another study (Seifi 
et al., 2007) reported that 16% of 1.162 cows tested in the first 8 days of lactation had ketosis. 
Recently, McArt et al. (2012), found that 43% of 1.717 cows in 4 dairy herds had at least one 
BHB test of 1.2 to 2.9 mmol/l, which they defined as subclinical ketosis, when tested 6 times 
between 3 and 16 DIM. Ketosis incidence may vary with different case definitions but we can 
state that our sample was in agreement with latest epidemiological surveys on subclinical 
ketosis since we concluded that between 24 and 34% of recruited cows within each herd and 
16 DIM had plasma BHB > 1.4 mmol/l. A greater severity of ketosis in older cows as in our 
sample is a consequence of a more severe refusing of food intake during transition and a rapid 
fat mobilization of more obese animals compared to heifers (Hayirli et al., 2002b). Cows with 
ketosis were expected to show low tissue responsiveness to insulin and low insulin 
concentrations (Holtenius, 1993; Sakai et al., 1993; Steen et al., 1997). 
NEFA concentrations are a marker of fat mobilization in states of negative energy balance 
(Mulligan et al., 2006). Ketosis and energy balance in transition cows should be monitored by 
measuring the proportion of animals above a certain biological cut-point of test results, 
specifically NEFA in close-up and BHB in post-calving cows, within the subsample (Oetzel, 2006). 
Low NEFA and BHB concentrations are of little to no significance to the cow and the cows are 
affected only when these parameters are elevated above alarm levels. Therefore we were less 
concerned with the mean value of the tested groups and we aimed at interpreting herd results 
on a proportional basis through risk analysis. Levels of approximately 0.3 mEq/l of pre-partum 
NEFA and 0.7 mEq/l post-partum have recently been identified as critical limit for predicting 
diseases risk after calving (Ospina et al., 2010). The same author demonstrated that although 
both elevated NEFA, pre and post-partum, and BHB post-partum are significantly associated 
with development of clinical ketosis, metritis, displaced abomasum and retained placenta 
within 30 DIM, postpartum serum NEFA is most associated with this risk. We used 0.5 mEq/L of 
NEFA Week -1 and 1.0 mEq/l of NEFA Week +1 as thresholds for classification of animals. A 
significant relative risk was found only pre-partum by comparing NEFA class and GTT class; 
absence of RR of GTT class 1 cows to experience ketosis, high NEFA or any other disease after 
calving can be due to treatments interference: although we tried to avoid blood collections 
within 24 h from any treatments, a certain influence from pharmacological therapies cannot be 
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excluded in a field trial such this. Other researchers have encountered difficulties in analyzing 
these kinds of data. Drackley (1999) affirmed that: “The transition period presents several 
challenges to the conduct of research. Perhaps the biggest challenge is that events happen 
quickly and physiological state changes rapidly, with most of the adaptations probably 
completed within about a 4-wk period from 2 wk before to 2 wk after calving. Measurements 
during this time are fraught with a high degree of variability, reflecting differences among 
individual cows in the success of adaptation to lactation. […] The high incidence of health 
problems during this time contributes to the variation in DMI, milk yield, and responses to 
imposed treatments. Lack of suitable covariate measurements makes analysis more difficult 
and requires larger numbers of cows to detect differences statistically. [...] Finally, treatments 
may be confounded by the changes in facilities and environments that the cows may be moved 
through during the transition period.” 
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6.3 The surrogate markers of insulin sensitivity: RQUICKI and HOMA 
An agreement between pre-partum GTT results and surrogate markers of insulin sensitivity, 
RQUICKI and HOMA, was stressed after calving. In recent research, Kerestes et al. (2009) did 
not obtain any relevant correlation between GTT parameters and the RQUICKI, whereas Balogh 
et al. (2008) have already identified a significant relationship between some variables derived 
by GTT and the RQUICKI. A low RQUICKI index value indicates decreased insulin sensitivity. On 
the other side, the higher HOMA-IR, the higher is IR and the lower is insulin sensitivity. Both a 
lower RQUICKI and higher HOMA in class 1 cows for pre-partum GTT confirmed our 
expectations of an overall reduced insulin sensitivity in animals not responding to GTT within 80 
minutes from infusion. As regards HOMA calculation, other researchers (Kusenda, 2010) have 
used a different equation, that is HOMA = G T0 x I T0 according to Matthews et al., (1985), 
whereas the denominator used in our formula would be specific for humans (Singh and Saxena, 
2010). The denominator of 22.5 in our formula is a normalizing factor and derives from the 
product of normal fasting blood glucose (4.5 mmol/L) and insulin (5 μU/mL) in typical “healthy 
humans” (Muniyappa et al., 2008).  However, it was hard to determine “normal” reference 
glucose and insulin levels in the first weeks of lactation in dairy cows to estimate a specific 
constant for HOMA in this species.  Overall both HOMA calculation methods used by these 
authors have led to statistically significant differences and similar patterns in their trends and IR 
identification before and after calving in line with other studies (Sano et al., 1993; Hayirli et al., 
2006). It can be noted that herds B and C had a lower HOMA in Week -1 compared to herd A, 
which is expression of a greater insulin sensitivity of these 2 herds pre-partum. This outcome is 
conflicting with their lower RQUICKI after calving, which on the contrary reveals minor insulin 
sensitivity. Again, a more pronounced lowered insulin production in numerous cows at less 
than 7 days pre-partum in these two herds could be responsible for this finding. Perhaps the 
use of HOMA to test IR in the proximity of calving should be avoided. The R.O.C. curves have 
ultimately declared RQUICKI and HOMA as poorly accurate diagnostic test for classification of 
cows recovering from glucose tolerance test. In effect, despite a rather clear distinction 
between herds when considering patterns of plasma metabolites, such as NEFA, urea, GOT-AST 
and GPT-ALT, in pre-partum weeks, the distribution of cows on the basis of FGTT was almost 
the same within each herd and the test had difficulties in underlining differences of metabolic 
status at the herd level. However, it must be admitted that the same differences between herds 
were not as easily recognizable by hematochemical parameters, diseases incidence and 
treatments frequency after calving as in pre-partum scenario. Although pre-analytical handling 
of samples, any kind of stress and feed consumption can affect baseline glucose, NEFA and 
insulin concentrations (Quiroz-Rocha et al. 2010; Leroy et al. 2010) and should be carefully 
considered before interpretation of any results, RQUICKI and HOMA would be likely best 
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indicators of insulin sensitivity per se than a single GTT. A further limitation of GTT could be the 
loss of glucose by urinary excretion after intravenous infusion or a rapid consumption by the 
mammary gland for colostrum synthesis and by placenta in late gestation since the absorption 
of glucose through these organs is insulin-independent. Cows enrolled within one single day 
before parturition were excluded from the trial. Anyway, these animals reported evident higher 
glucose levels at T80 at first sight. This observation could be associated to a considerable 
glucose intolerance at the time of calving and its physiological mechanisms should be better 
understood and fluid therapy with glucose solutions carefully assessed in clinical practice during 
this very delicate phase.  
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6.5 Conclusions 
In conclusion, our study demonstrates a promising opportunity for application of surrogate 
indices of insulin sensitivity and GTT in field trials to detect insulin resistance syndrome in dairy 
cows in the future. The T80/T0 ratio derived by GTT seemed to be useful in detecting a low 
insulin secretion as a likely complication of altered glucose uptake following glucose load in 
transition cows. Withal, it positively correlates with negative energy balance represented by 
NEFA concentrations in the 2 weeks before calving. These findings deserve further research 
about the epidemiology of IR syndrome at the herd level and among herds; its correlation with 
several pathological conditions commonly found in the transition cows should also be 
investigated. However, establishment of standardized tests protocols, strategies to minimize 
stress and feed delivery interferences under field conditions, and accurate analytical procedure, 
in particular for insulin and glucose, is worthwhile before further experimentation on this topic. 
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